Role of genes and environments for explaining Alzheimer disease.
paper
Cited
Public
Unavailable
- Authors
- Gatz, Margaret; Reynolds, Chandra A; Fratiglioni, Laura; Johansson, Boo; Mortimer, James A; Berg, Stig; Fiske, Amy; Pedersen, Nancy L
- Year
- 2006
- Journal
- Archives of general psychiatry
- PMID
- 16461860
- DOI
- 10.1001/archpsyc.63.2.168
CONTEXT: Twin studies using selected samples have shown high heritability for Alzheimer disease (AD). OBJECTIVE: To evaluate genetic and environmental influences on AD in a fully ascertained population of older twins, including like- and unlike-sex pairs. DESIGN: Five-group quantitative genetic model: male monozygotic twins, female monozygotic twins, male dizygotic twins, female dizygotic twins, and unlike-sex twins. SETTING AND PARTICIPANTS: All twins in the Swedish Twin Registry aged 65 years and older. The study included 11,884 twin pairs, among whom were 392 pairs in which 1 or both members had AD. MAIN OUTCOME MEASURES: All individuals were screened for cognitive dysfunction. Suspected cases of dementia and their co-twins received complete clinical diagnostic evaluations for AD. Estimates of heritability, shared environmental influences, and nonshared environmental influences, adjusting for age, were derived from the twin data. RESULTS: Heritability for AD was estimated to be 58% in the full model and 79% in the best-fitting model, with the balance of variation explained by nonshared environmental influences. There were no significant differences between men and women in prevalence or heritability after controlling for age. Within pairs concordant for AD, intrapair difference in age at onset was significantly greater in dizygotic than in monozygotic pairs, suggesting genetic influences on timing of the disease. CONCLUSIONS: In the largest twin study to date, we confirmed that heritability for AD is high and that the same genetic factors are influential for both men and women. However, nongenetic risk factors also play an important role and might be the focus for interventions to reduce disease risk or delay disease onset.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. | 2022 | 36207451 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. | Palaniappan LP et al. | β | 2026 | β |
| Advances in Alzheimer's disease: mechanistic insights and therapeutic targets. | Jia YJ et al. | β | 2026 | β |
| A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis. | Lorenz SM et al. | β | 2026 | β |
| A novel presenilin 1 nucleotide mutation (M139I) and its pathological function in a Chinese family with early-onset Alzheimer's disease. | Li X et al. | β | 2026 | β |
| APOE4 reprograms microglial lipid metabolism in Alzheimer's disease: Mechanisms and therapeutic implications. | Chen J et al. | β | 2026 | β |
| Apolipoprotein E e4 Status Predicts Memory Performance and Daily Functioning in Aging Hispanic/Latino Adults. | Lozano J et al. | β | 2026 | β |
| Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health. | Maioli S et al. | β | 2026 | β |
| Dissecting Alzheimer's disease heritability across populations. | Liu S et al. | β | 2026 | β |
| Dynamic Fusion of Genomics and Functional Network Connectivity in UK Biobank Reveals Schizophrenia-Related SNP Manifolds. | Chen J et al. | β | 2026 | β |
| Early-life influences on the risk for later-life Alzheimer's and non-Alzheimer's dementia: A nearly full life course prospective cohort study. | Herd P et al. | β | 2026 | β |
| Genetic modifiers of APOE-Ξ΅4-associated cognitive decline. | Contreras AG et al. | β | 2026 | β |
| Genetic risk in Alzheimer's disease. | Pan Y et al. | β | 2026 | β |
| Genetics of PLCG2 expression and splicing relative to Alzheimer's disease risk. | Turner AK et al. | β | 2026 | β |
| Integrating contextual determinants and polygenic risk to examine dementia and late-life cognition in the Multi-Ethnic Study of Atherosclerosis. | Xue D et al. | β | 2026 | β |
| Interactions between rare variants in DNA repair genes and cardiometabolic risk explain more variability in cognitive function. | Cherbuin N et al. | β | 2026 | β |
| Large-Scale Genotype-Based Trait Imputation With Multi-Ancestry GWAS Data. | Ren J et al. | β | 2026 | β |
| Mapping individual molecular connectomes in Alzheimer's disease. | Xu Z et al. | β | 2026 | β |
| Multi-biofluid metabolomics coupled with gene network reveals stage-specific alterations in mild cognitive impairment and Alzheimer's disease in an ethnically mixed cohort. | Cadaxo AS et al. | β | 2026 | β |
| Neuroimaging PheWAS and molecular phenotyping implicate PSMC3 in Alzheimer's disease. | Bledsoe X et al. | β | 2026 | β |
| Potential common pathogenesis of several neurodegenerative diseases. | Fan T et al. | β | 2026 | β |
| Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study. | Cheng B et al. | β | 2026 | β |
| scTWAS: a powerful statistical framework for single-cell transcriptome-wide association studies. | Lin Z et al. | β | 2026 | β |
| Short tandem repeat expansions in patients with neurodegenerative dementia. | Zhu Y et al. | β | 2026 | β |
| Summary-data-based Mendelian Randomization Analysis Identifies Nominal Evidence for Association of N6-Methyladenosine Genetic Variation with Alzheimer's Disease. | Rahman MR et al. | β | 2026 | β |
| The association of Alzheimer's disease-related SNPs with mild cognitive impairment susceptibility in the Chinese population. | Xie Z et al. | β | 2026 | β |
| The brain neurovascular epigenome and its association with dementia. | Ziegler KC et al. | β | 2026 | β |
| The functional minisatellite at the 3'-UTR of SLC6A3/DAT1 and dementia spectrum disorders: an association study in a population of Central Italy. | Torbidoni-Baldassari B et al. | β | 2026 | β |
| Unraveling the genetic interplay between sleep disorders and Alzheimer's disease: From shared genes to potential therapeutic targets. | Gao X et al. | β | 2026 | β |
| 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. | Martin SS et al. | β | 2025 | β |
| A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease. | Ehn E et al. | β | 2025 | β |
| Alzheimer disease is (sometimes) highly heritable: Drivers of variation in heritability estimates for binary traits, a systematic review. | Liu S et al. | β | 2025 | β |
| Alzheimer's Disease and <i>Porphyromonas gingivalis</i>: Exploring the Links. | Shawkatova I et al. | β | 2025 | β |
| Alzheimer's disease genetic risk: Top African American risk allele frequencies and genetic architecture among Mexican-, African-, and non-Hispanic White Americans. | Housini M et al. | β | 2025 | β |
| Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy. | Zheng Q et al. | β | 2025 | β |
| Alzheimer's disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function. | Yamakawa A et al. | β | 2025 | β |
| Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset. | Leung YY et al. | β | 2025 | β |
| An imaging and genetic-based deep learning network for Alzheimer's disease diagnosis. | Li Y et al. | β | 2025 | β |
| An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies. | Hasan A et al. | β | 2025 | β |
| Applications of Machine Learning for Cognitive Health in Older Individuals With HIV: Rapid Systematic Review. | Cho H et al. | β | 2025 | β |
| A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab. | Yan L et al. | β | 2025 | β |
| Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions. | Ren F et al. | β | 2025 | β |
| Association between apolipoprotein E Ξ΅4 status and the risk of Alzheimer's disease: a meta-analysis. | Ren Z et al. | β | 2025 | β |
| Association of genetic scores related to insulin resistance with neurological outcomes in ancestrally diverse cohorts from the Trans-Omics for Precision Medicine (TOPMed) program. | Sarnowski C et al. | β | 2025 | β |
| Association of rare <i>APOE</i> missense variants with Alzheimer's disease in the Japanese population. | Miyashita A et al. | β | 2025 | β |
| Associations between dementia and exposure to topical glaucoma medications. | Davidson O et al. | β | 2025 | β |
| Astrocytic and microglial cell functions in neuroinflammatory diseases and their animal models. | Hashimoto K et al. | β | 2025 | β |
| A Systems Biology Approach to Memory Health: Integrating Network Pharmacology, Gut Microbiota, and Multi-Omics for Health Functional Foods. | Yuan H et al. | β | 2025 | β |
| BIN1 and Alzheimer's disease: the tau connection. | Dourlen P et al. | β | 2025 | β |
| Biomarker identification for Alzheimer's disease through integration of comprehensive Mendelian randomization and proteomics data. | Zhan H et al. | β | 2025 | β |
| Brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease. | Mews MA et al. | β | 2025 | β |
| Brain morphology mediating the effects of common genetic risk variants on Alzheimer's disease. | Breddels EM et al. | β | 2025 | β |
| Calpain and caspase regulate AΞ² peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2. | Najdek C et al. | β | 2025 | β |
| Causal association of sex hormone-related traits with Alzheimer's disease: a multivariable and network Mendelian randomization analysis. | Zhang Y et al. | β | 2025 | β |
| CD2AP at the junction of nephropathy and Alzheimer's disease. | Vandal M et al. | β | 2025 | β |
| Common Variants in PLXNA4 and Correlation to Neuroimaging Phenotypes in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts. | Yang X et al. | β | 2025 | β |
| Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition. | Kim JP et al. | β | 2025 | β |
| Effect of time-restricted feeding on cognitive dysfunction in Alzheimer's disease and the role of ApoE polymorphism: protocol for a randomised controlled trial. | Chen J et al. | β | 2025 | β |
| Elevated BACE1 mRNA Level is Associated with Lower miR-15a-5p and miR-19b-3p Expressions in Peripheral Blood Mononuclear Cells of Patients with Late-Onset Alzheimer's Disease: Wet Lab Results and Bioinformatics Analysis. | Rasadi A et al. | β | 2025 | β |
| Enhancing nonlinear transcriptome- and proteome-wide association studies via trait imputation with applications to Alzheimer's disease. | He R et al. | β | 2025 | β |
| Enhancing the utility of polygenic scores in Alzheimer's disease through systematic curation and annotation. | Mwesigwa S et al. | β | 2025 | β |
| Epigenetics in evolution and adaptation to environmental challenges: pathways for disease prevention and treatment. | Abdolmaleky HM et al. | β | 2025 | β |
| Epigenetics in Neurodegenerative Diseases. | van Zundert B et al. | β | 2025 | β |
| Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease. | Rubino E et al. | β | 2025 | β |
| Fair positive unlabeled learning for predicting undiagnosed Alzheimer's disease in diverse electronic health records. | Tran T et al. | β | 2025 | β |
| From variants to mechanisms: Neurogenomics in the post-GWAS era. | Margolis MP et al. | β | 2025 | β |
| Functional insight into East Asian-specific genetic risk loci for Alzheimer's disease. | Cho M et al. | β | 2025 | β |
| Genetic association analyses of cognitive performance across multi-ancestry older adults: Application of Tobit models. | Wu X et al. | β | 2025 | β |
| Genetic Correlations and Causalities between Alzheimer's Disease and 35 Biomarkers in Blood and Urine. | Zhang S et al. | β | 2025 | β |
| Genetic PrΞΏpensity for Different Aspects of Dementia Pathology and Cognitive Decline in a Community Elderly Population. | Sampatakakis SN et al. | β | 2025 | β |
| Genetic risk for neurodegenerative conditions is linked to disease-specific microglial pathways. | Askarova A et al. | β | 2025 | β |
| Harmonizing genotype array data to understand genetic risk for brain amyloid burden in the AMYPAD PNHS Consortium. | Luckett ES et al. | β | 2025 | β |
| Heritability and shared environmental effects of brain diseases in 12,040 extended families. | Dijkstra JIR et al. | β | 2025 | β |
| Heterogeneity analysis provides evidence for a genetically homogeneous subtype of bipolar-disorder. | McGrouther CC et al. | β | 2025 | β |
| Human microglia differentially respond to Ξ²-amyloid, tau, and combined Alzheimer's disease pathologies in vivo. | Coburn MA et al. | β | 2025 | β |
| Identification of Alzheimer's disease susceptibility genes by integrating eight human brain single-cell transcriptomes with genome-wide association studies. | He Y et al. | β | 2025 | β |
| Identifying Alzheimer's disease-related pathways based on whole-genome sequencing data. | Wang Y et al. | β | 2025 | β |
| Integrating rare pathogenic variant prioritization with gene-based association analysis to identify novel genes and relevant multimodal traits for Alzheimer's disease. | Cao J et al. | β | 2025 | β |
| Integrative bioinformatics analysis of APOE variants in Alzheimer's disease and clinical therapeutics. | Srivastava K et al. | β | 2025 | β |
| Integrative multi-omics approaches identify molecular pathways and improve Alzheimer's disease risk prediction. | Venkatesh R et al. | β | 2025 | β |
| Interconnected Pathways of Alzheimer's Disease and Osteoporosis: A Review of Genetic, Hormonal, and Environmental Influences. | Li YX et al. | β | 2025 | β |
| Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function. | Liu Y et al. | β | 2025 | β |
| KIAA0319 modulates Alzheimer's disease risk through PMM2 regulation: Evidence from integrated pQTL-mediation and transcriptomic analyses. | Wen P et al. | β | 2025 | β |
| Leveraging multimodal neuroimaging and GWAS for identifying modality-level causal pathways to Alzheimer's disease. | Tian Y et al. | β | 2025 | β |
| Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research. | Szegvari E et al. | β | 2025 | β |
| Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment. | Mourtzi N et al. | β | 2025 | β |
| Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum. | Ali M et al. | β | 2025 | β |
| Multi-omic derived cell-type specific Alzheimer disease polygenic risk scores. | O'Neill N et al. | β | 2025 | β |
| Multivariate proteome-wide association study to identify causal proteins for Alzheimer disease. | Fang L et al. | β | 2025 | β |
| Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer's disease, and its consequences for research in genetics. | Xavier C et al. | β | 2025 | β |
| Neuroinflammation in Alzheimer disease. | Heneka MT et al. | β | 2025 | β |
| Neuronal ABCA7 deficiency aggravates mitochondrial dysfunction and neurodegeneration in Alzheimer's disease. | Wang N et al. | β | 2025 | β |
| Overview and Regional Context of Alzheimer's Disease in the Middle East and North Africa Region. | Dhillon A et al. | β | 2025 | β |
| Patient stratification by genetic risk in Alzheimer's disease is only effective in the presence of phenotypic heterogeneity. | Euesden J et al. | β | 2025 | β |
| Pluripotent Cells Expressing APOE4 Exhibit a Pronounced Pro-Apoptotic Phenotype Accompanied by Markers of Hyperinflammation and a Blunted NF-ΞΊB Response. | Schulten W et al. | β | 2025 | β |
| Polygenic risk discriminates Lewy body dementia from Alzheimer's disease. | McKeever A et al. | β | 2025 | β |
| Potential multiple disease progression pathways in female patients with Alzheimer's disease inferred from transcriptome and epigenome data of the dorsolateral prefrontal cortex. | Honda K et al. | β | 2025 | β |
| Predictive regression models for cognitive impairment, dementia, and Alzheimer's disease using real-world electronic health records. | Yubero R et al. | β | 2025 | β |
| Ramp Sequence May Explain Synonymous Variant Association with Alzheimer's Disease in the Paired Immunoglobulin-like Type 2 Receptor Alpha (PILRA). | Miller JB et al. | β | 2025 | β |
| Recent Advances in Drug Development for Alzheimer's Disease: A Comprehensive Review. | Xing H et al. | β | 2025 | β |
| Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP): A global effort to identify genetic factors in Alzheimer's disease. | Akinyemi R et al. | β | 2025 | β |
| Regional Differences in Dementia Incidence Among US Veterans. | Dintica CS et al. | β | 2025 | β |
| Risk score roulette: A cautionary tale of polygenic risk score reliability. | Xue D et al. | β | 2025 | β |
| Serum proteomics reveals early biomarkers of Alzheimer's disease: The dual role of APOE-Ξ΅4. | Ma YN et al. | β | 2025 | β |
| Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across Ancestries. | Xu X et al. | β | 2025 | β |
| Shared genes and pathways in dementia: Insights from genome-wide association studies. | Loi KJ et al. | β | 2025 | β |
| Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020: A Target Trial Emulation Study. | Zimmerman SC et al. | β | 2025 | β |
| Structural variation detection and association analysis of whole-genome-sequence data from 16,543 Alzheimer's disease sequencing project subjects. | Wang H et al. | β | 2025 | β |
| Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue. | Aguzzoli Heberle B et al. | β | 2025 | β |
| The Genetics of Amyloid Deposition: A Systematic Review of Genome-Wide Association Studies Using Amyloid PET Imaging in Alzheimer's Disease. | Amanullah AA et al. | β | 2025 | β |
| The impact of rare genetic variants on Alzheimer disease. | De Deyn L et al. | β | 2025 | β |
| The Role of Neprilysin and Insulin-Degrading Enzyme in the Etiology of Sporadic Alzheimer's Disease. | Morito T et al. | β | 2025 | β |
| The silent struggle of ageing with SMI: a narrative review of physical health disparities in older adults with serious mental illness. | Howe J et al. | β | 2025 | β |
| The Spectrum of Genetic Risk in Alzheimer Disease. | Karagas N et al. | β | 2025 | β |
| Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations. | Nicolas A et al. | β | 2025 | β |
| Triple-mode sensing platform for acetylcholinesterase activity monitoring and anti-Alzheimer's drug screening based on a highly stable Cu (I) compound. | Cai Y et al. | β | 2025 | β |
| Type 2 diabetes and late-onset Alzheimer's disease and related dementia: A longitudinal cohort study integrating polygenic risk score. | Jeong S et al. | β | 2025 | β |
| Uncertainty-aware genomic classification of Alzheimer's disease: a transformer-based ensemble approach with Monte Carlo dropout. | Jo T et al. | β | 2025 | β |
| Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases. | Karati D et al. | β | 2025 | β |
| Validate association of gene loci and establish genetic risk prediction models for late-onset Alzheimer's disease in Chinese populations. | Li F et al. | β | 2025 | β |
| Whole-genome sequencing analyses suggest novel genetic factors associated with Alzheimer's disease and a cumulative effects model for risk liability. | Kim JP et al. | β | 2025 | β |
| 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. | Martin SS et al. | β | 2024 | β |
| African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181. | Rajabli F et al. | β | 2024 | β |
| Altered Motor Activity Patterns within 10-Minute Timescale Predict Incident Clinical Alzheimer's Disease. | Sun H et al. | β | 2024 | β |
| Alzheimer's disease: part 2 - the present. | Nitrini R | β | 2024 | β |
| Alzheimer's diseases in America, Europe, and Asian regions: a global genetic variation. | Hossain R et al. | β | 2024 | β |
| Andrographolide Improves ApoE4-Mediated Blood-Brain Barrier Injury by Alleviating Inflammation. | Zhou X et al. | β | 2024 | β |
| An Effective DNA Methylation Biomarker Screening Mechanism for Amyotrophic Lateral Sclerosis (ALS) Based on Comorbidities and Gene Function Analysis. | Yang CH et al. | β | 2024 | β |
| An interpretable deep learning framework identifies proteomic drivers of Alzheimer's disease. | Panizza E et al. | β | 2024 | β |
| An overview on microglial origin, distribution, and phenotype in Alzheimer's disease. | Islam R et al. | β | 2024 | β |
| A philosophy of science approach to the amyloid hypothesis of Alzheimer's disease. | Daly T | β | 2024 | β |
| Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice. | Ritchie M et al. | β | 2024 | β |
| Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening. | Nicolas G et al. | β | 2024 | β |
| Association between abnormal lipid metabolism and Alzheimer's disease: New research has revealed significant findings on the APOE4 genotype in microglia. | Hu X et al. | β | 2024 | β |
| Association between pre-dementia psychiatric diagnoses and all-cause dementia is independent from polygenic dementia risks in the UK Biobank. | Freudenberg-Hua Y et al. | β | 2024 | β |
| Association of <i>MME</i> gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population. | Khalili-Moghadam F et al. | β | 2024 | β |
| Association of polygenic risk scores with Alzheimer's disease and plasma biomarkers among Chinese older adults: A community-based study. | Hou T et al. | β | 2024 | β |
| Association of whole-person eigen-polygenic risk scores with Alzheimer's disease. | Kharaghani A et al. | β | 2024 | β |
| Associations among dietary 1-carbon metabolism nutrients, genetic risk, and Alzheimer disease: a prospective cohort study. | Wang Y et al. | β | 2024 | β |
| Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia. | Guo S et al. | β | 2024 | β |
| Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease. | Fu Y et al. | β | 2024 | β |
| Cell type-specific functions of Alzheimer's disease endocytic risk genes. | Maninger JK et al. | β | 2024 | β |
| Charting Alzheimer's Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways. | Contador I et al. | β | 2024 | β |
| Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain development. | Jaholkowski P et al. | β | 2024 | β |
| Cognitively healthy centenarians are genetically protected against Alzheimer's disease. | Tesi N et al. | β | 2024 | β |
| Comparative study of machine learning methods for modeling associations between risk factors and future dementia cases. | ValsdΓ³ttir V et al. | β | 2024 | β |
| Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia. | Reus LM et al. | β | 2024 | β |
| Coupling of Alzheimer's Disease Genetic Risk Factors with Viral Susceptibility and Inflammation. | Cao C et al. | β | 2024 | β |
| CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer's disease-risk variant, SHARPIN G186R, reveal reduced NF-ΞΊB pathway and accelerated AΞ² secretion. | Asanomi Y et al. | β | 2024 | β |
| Cross-phenotype associations between Alzheimer's Disease and its comorbidities may provide clues to progression. | Moore A et al. | β | 2024 | β |
| Deciphering the tissue-specific functional effect of Alzheimer risk SNPs with deep genome annotation. | Pugalenthi PV et al. | β | 2024 | β |
| Dementia and mortality in older adults: A twin study. | Jang JY et al. | β | 2024 | β |
| Detecting the effect of genetic diversity on brain composition in an Alzheimer's disease mouse model. | Gurdon B et al. | β | 2024 | β |
| Detecting time-varying genetic effects in Alzheimer's disease using a longitudinal genome-wide association studies model. | Zhuang X et al. | β | 2024 | β |
| Development of the Brazilian version of the Mini-Addenbrooke Cognitive Examination (M-ACE BR) to screen for cognitive impairment in older adults. | Okada-Oliveira M et al. | β | 2024 | β |
| Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults. | Thompson LI et al. | β | 2024 | β |
| Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach. | Dai Y et al. | β | 2024 | β |
| Editorial: Meeting new challenges in translationally relevant neurodegenerative disease research. | Latimer CS et al. | β | 2024 | β |
| Employing Informatics Strategies in Alzheimer's Disease Research: A Review from Genetics, Multiomics, and Biomarkers to Clinical Outcomes. | Bao J et al. | β | 2024 | β |
| Epigenetic modifications of DNA and RNA in Alzheimer's disease. | Martinez-Feduchi P et al. | β | 2024 | β |
| Ethical issues in genomics research in persons with Alzheimer's Disease/Alzheimer's Disease-related dementia (AD/ADRD): a systematic review. | Yakubu A et al. | β | 2024 | β |
| Exploring first-degree family history in a cohort of Portuguese Alzheimer's disease patients: population evidence for X-chromosome linked and recessive inheritance of risk factors. | TΓ‘buas-Pereira M et al. | β | 2024 | β |
| Exploring the Genetic Heterogeneity of Alzheimer's Disease: Evidence for Genetic Subtypes. | Elman JA et al. | β | 2024 | β |
| Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions. | Choi HK et al. | β | 2024 | β |
| Genetic diversity promotes resilience in a mouse model of Alzheimer's disease. | Soni N et al. | β | 2024 | β |
| Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence. | Enduru N et al. | β | 2024 | β |
| Genome-wide association analysis and admixture mapping in a Puerto Rican cohort supports an Alzheimer disease risk locus on chromosome 12. | Akgun B et al. | β | 2024 | β |
| Genome-wide meta-analysis identifies ancestry-specific loci for Alzheimer's disease. | Ge YJ et al. | β | 2024 | β |
| Genomic Machine Learning Meta-regression: Insights on Associations of Study Features With Reported Model Performance. | Barnett EJ et al. | β | 2024 | β |
| Identification of common core ion channel genes in epilepsy and Alzheimer's disease. | Tang T et al. | β | 2024 | β |
| Identifying flaws in the GWAS datasets of a published Mendelian randomization study: complementary re-evaluation and suggestion for analytical refinements. | Xiang JC et al. | β | 2024 | β |
| Identifying the earliest-occurring clinically targetable precursors of late-onset Alzheimer's disease. | Cohen BM et al. | β | 2024 | β |
| Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies. | Pazzin DB et al. | β | 2024 | β |
| Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study. | Waterink L et al. | β | 2024 | β |
| Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types. | Holtman IR et al. | β | 2024 | β |
| Is the Relationship Between Cardiovascular Disease and Alzheimer's Disease Genetic? A Scoping Review. | Moore A et al. | β | 2024 | β |
| Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022. | Kong F et al. | β | 2024 | β |
| Lessons from genetic studies in Alzheimer disease. | Nicolas G | β | 2024 | β |
| Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer's disease. | Baril AA et al. | β | 2024 | β |
| Longitudinal change in memory performance as a strong endophenotype for Alzheimer's disease. | Archer DB et al. | β | 2024 | β |
| LRRC25 expression during physiological aging and in mouse models of Alzheimer's disease and iPSC-derived neurons. | Devadoss D et al. | β | 2024 | β |
| Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes. | Gunter NB et al. | β | 2024 | β |
| Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks. | Eysert F et al. | β | 2024 | β |
| Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease. | Bhalala OG et al. | β | 2024 | β |
| Multivariate mediation analysis with voxel-based morphometry revealed the neurodegeneration pathways from genetic variants to Alzheimer's Disease. | Mu S et al. | β | 2024 | β |
| Polygenic effects on the risk of Alzheimer's disease in the Japanese population. | Kikuchi M et al. | β | 2024 | β |
| Prioritizing disease-related rare variants by integrating gene expression data. | Guo H et al. | β | 2024 | β |
| Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease. | Armstrong P et al. | β | 2024 | β |
| Recent advances in Alzheimer disease genetics. | Nicolas G | β | 2024 | β |
| Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions. | Prasanth MI et al. | β | 2024 | β |
| Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions. | Sakowski SA et al. | β | 2024 | β |
| Serum proteomics reveal APOE-Ξ΅4-dependent and APOE-Ξ΅4-independent protein signatures in Alzheimer's disease. | Frick EA et al. | β | 2024 | β |
| Shared whole environmental etiology between Alzheimer's disease and age-related macular degeneration. | Ye S et al. | β | 2024 | β |
| Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets. | Sharma Y et al. | β | 2024 | β |
| Subtype-specific neurons from patient iPSCs display distinct neuropathological features of Alzheimer's disease. | Tao R et al. | β | 2024 | β |
| Supervised latent factor modeling isolates cell-type-specific transcriptomic modules that underlie Alzheimer's disease progression. | Hodgson L et al. | β | 2024 | β |
| The ABC's of Alzheimer risk gene ABCA7. | Duchateau L et al. | β | 2024 | β |
| The broken Alzheimer's disease genome. | Gouveia Roque C et al. | β | 2024 | β |
| The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms. | de Vries LE et al. | β | 2024 | β |
| The endotoxin hypothesis of Alzheimer's disease. | Brown GC et al. | β | 2024 | β |
| The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer's disease in APOE Ξ΅ 4-negative Japanese adults. | Shigemizu D et al. | β | 2024 | β |
| The Importance of Complement-Mediated Immune Signaling in Alzheimer's Disease Pathogenesis. | Batista AF et al. | β | 2024 | β |
| The power of representation: Statistical analysis of diversity in US Alzheimer's disease genetics data. | Xue D et al. | β | 2024 | β |
| Time trends in Alzheimer's disease mortality attributable to metabolic risks and smoking in China from 1990 to 2019: an age-period-cohort analysis. | Sun S et al. | β | 2024 | β |
| Transcriptional risk scores in Alzheimer's disease: From pathology to cognition. | Pyun JM et al. | β | 2024 | β |
| Trends in the application of "omics" to Alzheimer's disease: a bibliometric and visualized study. | Tan Y et al. | β | 2024 | β |
| Unraveling the genetic architecture of blood unfolded p-53 among non-demented elderlies: novel candidate genes for early Alzheimer's disease. | Yaghoobi A et al. | β | 2024 | β |
| Whole exome sequencing analyses identified novel genes for Alzheimer's disease and related dementia. | Zhang YR et al. | β | 2024 | β |
| Whole-genome sequencing study in Koreans identifies novel loci for Alzheimer's disease. | Kang M et al. | β | 2024 | β |
| Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease. | Xicota L et al. | β | 2024 | β |
| ABCA7-Associated Clinical Features and Molecular Mechanisms in Alzheimer's Disease. | Qian XH et al. | β | 2023 | β |
| AD-Syn-Net: systematic identification of Alzheimer's disease-associated mutation and co-mutation vulnerabilities via deep learning. | Pan X et al. | β | 2023 | β |
| A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease. | Esteban-Martos A et al. | β | 2023 | β |
| A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores. | Kang M et al. | β | 2023 | β |
| A global view of the genetic basis of Alzheimer disease. | Reitz C et al. | β | 2023 | β |
| A History of Repeated Alcohol Intoxication Promotes Cognitive Impairment and Gene Expression Signatures of Disease Progression in the 3xTg Mouse Model of Alzheimer's Disease. | Sanna PP et al. | β | 2023 | β |
| A longitudinal study of polygenic score and cognitive function decline considering baseline cognitive function, lifestyle behaviors, and diabetes among middle-aged and older US adults. | Liu T et al. | β | 2023 | β |
| Alzheimer's disease: The role of T lymphocytes in neuroinflammation and neurodegeneration. | Asamu MO et al. | β | 2023 | β |
| Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years. | Stocker H et al. | β | 2023 | β |
| Analysis of complement system and its related factors in Alzheimer's disease. | Zhu XC et al. | β | 2023 | β |
| Analysis of endothelial gene polymorphisms in Spanish patients with vascular dementia and AlzheimerΒ΄s disease. | Manso-CalderΓ³n R et al. | β | 2023 | β |
| An inclusive study of recent advancements in Alzheimer's disease: A comprehensive review. | Singh S et al. | β | 2023 | β |
| Applications of artificial intelligence in dementia research. | Tsoi KKF et al. | β | 2023 | β |
| Are Ischemic Stroke and Alzheimer's Disease Genetically Consecutive Pathologies? | Filippenkov IB et al. | β | 2023 | β |
| Artificial intelligence for dementia genetics and omics. | Bettencourt C et al. | β | 2023 | β |
| Association between polygenic risk for Alzheimer's disease and brain structure in children and adults. | He XY et al. | β | 2023 | β |
| Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition. | Li JQ et al. | β | 2023 | β |
| [Beneficial effects of ketogenic diet for Alzheimer's disease management]. | Charlot A et al. | β | 2023 | β |
| Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology. | Gouilly D et al. | β | 2023 | β |
| BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology. | Kaur I et al. | β | 2023 | β |
| Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries. | Adewale BA et al. | β | 2023 | β |
| Brain-wide genome-wide colocalization study for integrating genetics, transcriptomics and brain morphometry in Alzheimer's disease. | Bao J et al. | β | 2023 | β |
| Caffeine for Prevention of Alzheimer's Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target? | Merighi S et al. | β | 2023 | β |
| Cardiometabolic diseases, polygenic risk score, APOE genotype, and risk of incident dementia: A population-based prospective cohort study. | Chen Y et al. | β | 2023 | β |
| Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice. | Carr ST et al. | β | 2023 | β |
| Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population. | Kim BH et al. | β | 2023 | β |
| Clinical utility of polygenic risk scores: a critical 2023 appraisal. | Koch S et al. | β | 2023 | β |
| Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer's Disease. | Lalwani RC et al. | β | 2023 | β |
| Co-occurring pathogenic variants in 6q27 associated with dementia spectrum disorders in a Peruvian family. | Alvarez KLF et al. | β | 2023 | β |
| Deciphering dementia in the cardiometabolic continuum. | Fadini GP et al. | β | 2023 | β |
| Deep learning-based polygenic risk analysis for Alzheimer's disease prediction. | Zhou X et al. | β | 2023 | β |
| Detection, visualization and quantification of protein complexes in human Alzheimer's disease brains using proximity ligation assay. | Romero-Fernandez W et al. | β | 2023 | β |
| Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. | Xu Y et al. | β | 2023 | β |
| Environmental neurology: Concepts and short history of an interdisciplinary approach to etiology, treatment and prevention. | Reis J et al. | β | 2023 | β |
| Evaluating the Classification Accuracy of Expression Quantitative Trait Loci Calculated Polygenic Risk Scores in Alzheimer's Disease. | Brookes KJ | β | 2023 | β |
| Evolutionary and genomic perspectives of brain aging and neurodegenerative diseases. | Rigby Dames BA et al. | β | 2023 | β |
| Explainable machine learning aggregates polygenic risk scores and electronic health records for Alzheimer's disease prediction. | Gao XR et al. | β | 2023 | β |
| Explainable variational autoencoder (E-VAE) model using genome-wide SNPs to predict dementia. | Vivek S et al. | β | 2023 | β |
| Exploring the relationship between socioeconomic deprivation index and Alzheimer's disease using summary-level data: From genetic correlation to causality. | Dai J et al. | β | 2023 | β |
| Expression of <i>INPP5D</i> Isoforms in Human Brain: Impact of Alzheimer's Disease Neuropathology and Genetics. | Zajac DJ et al. | β | 2023 | β |
| Family History of AD/Dementia, Polygenic Risk Score for AD, and Parkinson's Disease. | Xu X et al. | β | 2023 | β |
| Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model. | Stolzenburg LR et al. | β | 2023 | β |
| Functional genomics identify causal variant underlying the protective CTSH locus for Alzheimer's disease. | Li Y et al. | β | 2023 | β |
| Functional variants identify sex-specific genes and pathways in Alzheimer's Disease. | Bourquard T et al. | β | 2023 | β |
| Genetic background influences the 5XFAD Alzheimer's disease mouse model brain proteome. | Hurst CD et al. | β | 2023 | β |
| Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease. | Nott A et al. | β | 2023 | β |
| Genetic propensity for cerebral amyloidosis and risk of mild cognitive impairment and Alzheimer's disease within a cognitive reserve framework. | Mourtzi N et al. | β | 2023 | β |
| Genetics of Alzheimer's disease: an East Asian perspective. | Miyashita A et al. | β | 2023 | β |
| Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study. | Zou H et al. | β | 2023 | β |
| Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. | Tsao CW et al. | β | 2023 | β |
| Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort. | Abraham Daniel A et al. | β | 2023 | β |
| <i>Caenorhabditis elegans</i> as a Model System to Study Human Neurodegenerative Disorders. | Roussos A et al. | β | 2023 | β |
| Identification of novel genes for age-at-onset of Alzheimer's disease by combining quantitative and survival trait analyses. | Li YJ et al. | β | 2023 | β |
| Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score. | Lai D et al. | β | 2023 | β |
| Identifying underlying patterns in Alzheimer's disease trajectory: a deep learning approach and Mendelian randomization analysis. | Yi F et al. | β | 2023 | β |
| Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging. | Supiyev A et al. | β | 2023 | β |
| Integrative Genomic Analysis of m6a-SNPs Identifies Potential Functional Variants Associated with Alzheimer's Disease. | Jan SM et al. | β | 2023 | β |
| <i>TOMM40</i> Genetic Variants Cause Neuroinflammation in Alzheimer's Disease. | Chen YC et al. | β | 2023 | β |
| Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease. | Ali M et al. | β | 2023 | β |
| Let's Not Repeat History's Mistakes: Two Cautions to Scientists on the Use of Race in Alzheimer's Disease and Alzheimer's Disease Related Dementias Research. | Stites SD et al. | β | 2023 | β |
| Life Experience Matters: Enrichment and Stress Can Influence the Likelihood of Developing Alzheimer's Disease via Gut Microbiome. | Torraville SE et al. | β | 2023 | β |
| Linear Mixed Model Analysis of Polygenic Hazard Score on Verbal Memory Decline in Alzheimer's Disease. | Wang K et al. | β | 2023 | β |
| Literature Overview of the Relation Between Psoriasis and Alzheimer. | Yang Q et al. | β | 2023 | β |
| Machine learning-based quantification for disease uncertainty increases the statistical power of genetic association studies. | Park JY et al. | β | 2023 | β |
| Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men. | GarcΓa-GonzΓ‘lez P et al. | β | 2023 | β |
| Minding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer's Disease. | Reed EG et al. | β | 2023 | β |
| Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer's disease patients are associated with cognitive impairment. | Xicota L et al. | β | 2023 | β |
| Monitoring clusterin and fibrillar structures in aging and dementia. | Trindade D et al. | β | 2023 | β |
| mRNA isoform balance in neuronal development and disease. | LaForce GR et al. | β | 2023 | β |
| Multi-layered transcriptomic analysis reveals a pivotal role of FMR1 and other developmental genes in Alzheimer's disease-associated brain ceRNA network. | Piergiorge RM et al. | β | 2023 | β |
| Neural network on interval-censored data with application to the prediction of Alzheimer's disease. | Sun T et al. | β | 2023 | β |
| Neurodegeneration cell per cell. | Balusu S et al. | β | 2023 | β |
| Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies. | Du L et al. | β | 2023 | β |
| Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease. | Li H et al. | β | 2023 | β |
| Obesity reduces hippocampal structure and function in older African Americans with the APOE-Ξ΅4 Alzheimer's disease risk allele. | Osiecka Z et al. | β | 2023 | β |
| Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers. | Schork NJ et al. | β | 2023 | β |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Vuic B et al. | β | 2023 | β |
| Polygenic Liability to Alzheimer's Disease Is Associated with a Wide Range of Chronic Diseases: A Cohort Study of 312,305 Participants. | Wu BS et al. | β | 2023 | β |
| Polygenic resilience score may be sensitive to preclinical Alzheimer's disease changes. | Eissman JM et al. | β | 2023 | β |
| Poorer sleep impairs brain health at midlife. | Namsrai T et al. | β | 2023 | β |
| Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPΞ² levels in cerebrospinal fluid and 2D/3D cell culture models. | Wittrahm R et al. | β | 2023 | β |
| Refining Risk for Alzheimer's Disease Among Heterozygous APOEΙ4 Carriers. | Patel S et al. | β | 2023 | β |
| Relationship Between <i>FERMT2</i>, <i>CELF1</i>, <i>COPI</i>, <i>CHRNA2</i>, and <i>ABCA7</i> Genetic Polymorphisms and Alzheimer's Disease Risk in the Southern Chinese Population. | Ding Y et al. | β | 2023 | β |
| Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system. | Fominykh V et al. | β | 2023 | β |
| Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues. | Vasconcelos CFM et al. | β | 2023 | β |
| Single-neuron whole genome sequencing identifies increased somatic mutation burden in Alzheimer's disease related genes. | Li Z et al. | β | 2023 | β |
| Stress and the risk of Alzheimer dementia: Can deconstructed engrams be rebuilt? | Jeanneteau F | β | 2023 | β |
| Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease. | Blanco K et al. | β | 2023 | β |
| The associations of APP, PSEN1, and PSEN2 genes with Alzheimer's disease: A large case-control study in Chinese population. | Xiao X et al. | β | 2023 | β |
| The Future of Cognitive Screening in Neurodegenerative Diseases. | Umfleet LG et al. | β | 2023 | β |
| The gut-brain vascular axis in neuroinflammation. | Carloni S et al. | β | 2023 | β |
| The Interaction Between NF-ΞΊB and Estrogen in Alzheimer's Disease. | Mishra P et al. | β | 2023 | β |
| The prediction of Alzheimer's disease through multi-trait genetic modeling. | Clark K et al. | β | 2023 | β |
| Top Alzheimer's disease risk allele frequencies differ in HABS-HD Mexican- versus Non-Hispanic White Americans. | Housini M et al. | β | 2023 | β |
| Transferability of European-derived Alzheimerβs Disease Polygenic Risk Scores across Multi-Ancestry Populations | Nicolas A et al. | β | 2023 | β |
| Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis. | Ciurea AV et al. | β | 2023 | β |
| Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity. | Yang M et al. | β | 2023 | β |
| Validation of newly derived polygenic risk scores for dementia in a prospective study of older individuals. | Yu C et al. | β | 2023 | β |
| VEGF controls microglial phagocytic response to amyloid-Ξ². | de Gea P et al. | β | 2023 | β |
| What does heritability of Alzheimer's disease represent? | Baker E et al. | β | 2023 | β |
| Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study. | Tomassen J et al. | β | 2022 | β |
| A functional variant of SHARPIN confers increased risk of late-onset Alzheimer's disease. | Asanomi Y et al. | β | 2022 | β |
| Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer's Disease. | Neshan M et al. | β | 2022 | β |
| Amyloid-Ξ² and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score. | Tomassen J et al. | β | 2022 | β |
| APOE Ι4 allele and TOMM40-APOC1 variants jointly contribute to survival to older ages. | Kulminski AM et al. | β | 2022 | β |
| Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance. | Grishanova AY et al. | β | 2022 | β |
| Association of Alzheimer's disease polygenic risk scores with amyloid accumulation in cognitively intact older adults. | Luckett ES et al. | β | 2022 | β |
| Association of <i>APOE</i>-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults. | Xicota L et al. | β | 2022 | β |
| Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer's disease. | Zhang X et al. | β | 2022 | β |
| Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer's Disease Risk. | Cao H et al. | β | 2022 | β |
| Association of the top 20 Alzheimer's disease risk genes with [<sup>18</sup>F]flortaucipir PET. | Stage E et al. | β | 2022 | β |
| Associations of fish oil supplementation with incident dementia: Evidence from the UK Biobank cohort study. | Huang Y et al. | β | 2022 | β |
| Associations of genetic liability for Alzheimer's disease with cognition and eye movements in a large, population-based cohort study. | Coors A et al. | β | 2022 | β |
| Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers. | Li Q et al. | β | 2022 | β |
| Associations of the APOE Ξ΅2 and Ξ΅4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease biomarkers. | Kulminski AM et al. | β | 2022 | β |
| Attention-deficit/hyperactivity disorder and Alzheimer's disease and any dementia: A multi-generation cohort study in Sweden. | Zhang L et al. | β | 2022 | β |
| Cell type-specific histone acetylation profiling of Alzheimer's disease subjects and integration with genetics. | Ramamurthy E et al. | β | 2022 | β |
| Characterization of Retinal Drusen in Subjects at High Genetic Risk of Developing Sporadic Alzheimer's Disease: An Exploratory Analysis. | LΓ³pez-Cuenca I et al. | β | 2022 | β |
| Copper induces microglia-mediated neuroinflammation through ROS/NF-ΞΊB pathway and mitophagy disorder. | Zhou Q et al. | β | 2022 | β |
| Dementia-related genetic variants in an Italian population of early-onset Alzheimer's disease. | Bartoletti-Stella A et al. | β | 2022 | β |
| Development and validation of immune-based biomarkers and deep learning models for Alzheimer's disease. | He Y et al. | β | 2022 | β |
| Differential Transcriptome Profiling Unveils Novel Deregulated Gene Signatures Involved in Pathogenesis of Alzheimer's Disease. | Singh HN et al. | β | 2022 | β |
| Disclosure of Genetic Risk Factors for Alzheimer's Disease to Cognitively Healthy Individuals-From Current Practice towards a Personalised Medicine Scenario. | Galluzzi S et al. | β | 2022 | β |
| Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum. | Toledo JB et al. | β | 2022 | β |
| Dissection of the polygenic architecture of neuronal AΞ² production using a large sample of individual iPSC lines derived from Alzheimer's disease patients. | Kondo T et al. | β | 2022 | β |
| Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology? | Groot C et al. | β | 2022 | β |
| Early-life educational attainment, APOE Ξ΅4 alleles, and incident dementia risk in late life. | Ma H et al. | β | 2022 | β |
| Economic evaluation of the screening for Alzheimer's disease in China. | Ren Y et al. | β | 2022 | β |
| Editorial: Dementia Prevention: A Global Challenge in Urgent Need of Solutions. | Price G et al. | β | 2022 | β |
| Endoplasmic reticulum stress induces Alzheimer disease-like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein. | Devina T et al. | β | 2022 | β |
| Epigenetic Changes and Chromatin Reorganization in Brain Function: Lessons from Fear Memory Ensemble and Alzheimer's Disease. | van Zundert B et al. | β | 2022 | β |
| Epigenetic regulation of synaptic disorder in Alzheimer's disease. | Chen Z et al. | β | 2022 | β |
| Estimating Likelihood of Dementia in the Absence of Diagnostic Data: A Latent Dementia Index in 10 Genetically Informed Studies. | Beam CR et al. | β | 2022 | β |
| Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA. | Salemi M et al. | β | 2022 | β |
| Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease. | Holstege H et al. | β | 2022 | β |
| Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease. | Salasova A et al. | β | 2022 | β |
| Functional insight into LOAD-associated microglial response genes. | Jonas LA et al. | β | 2022 | β |
| Genetically identical twins show comparable tau PET load and spatial distribution. | Coomans EM et al. | β | 2022 | β |
| Genetically predicted telomere length and its relationship with neurodegenerative diseases and life expectancy. | RodrΓguez-FernΓ‘ndez B et al. | β | 2022 | β |
| Genetic evidence that the causal association of educational attainment with reduced risk of Alzheimer's disease is driven by intelligence. | Thorp JG et al. | β | 2022 | β |
| Genetics of Alzheimer Disease. | Jayadev S | β | 2022 | β |
| Genome-wide association of polygenic risk extremes for Alzheimer's disease in the UK Biobank. | Gouveia C et al. | β | 2022 | β |
| Genome-wide association studies for Alzheimer's disease: bigger is not always better. | Escott-Price V et al. | β | 2022 | β |
| Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset. | Homann J et al. | β | 2022 | β |
| Genome-Wide Association Study of Incident Dementia in a Community-Based Sample of Older Subjects. | Harper JD et al. | β | 2022 | β |
| Genome-Wide association study of quantitative biomarkers identifies a novel locus for alzheimer's disease at 12p12.1. | Lee B et al. | β | 2022 | β |
| Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning. | Lahti J et al. | β | 2022 | β |
| Genomics and Functional Genomics of Alzheimer's Disease. | Kamboh MI | β | 2022 | β |
| Hypothesis on ontogenesis and pathophysiology of Alzheimer's disease. | Schwab EDP et al. | β | 2022 | β |
| Identification and Quantitation of Novel <i>ABI3</i> Isoforms Relative to Alzheimer's Disease Genetics and Neuropathology. | Turner AK et al. | β | 2022 | β |
| Identification of Differential Genes of DNA Methylation Associated With Alzheimer's Disease Based on Integrated Bioinformatics and Its Diagnostic Significance. | Chen F et al. | β | 2022 | β |
| Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through immune landscape analysis. | Shigemizu D et al. | β | 2022 | β |
| Identifying Alzheimer's genes via brain transcriptome mapping. | Baik JY et al. | β | 2022 | β |
| Identifying genetic markers enriched by brain imaging endophenotypes in Alzheimer's disease. | Kim M et al. | β | 2022 | β |
| Improving mouse models for the study of Alzheimer's disease. | Reagan AM et al. | β | 2022 | β |
| Improving polygenic prediction with genetically inferred ancestry. | Naret O et al. | β | 2022 | β |
| Integrated analysis of direct and proxy genome wide association studies highlights polygenicity of Alzheimer's disease outside of the APOE region. | de la Fuente J et al. | β | 2022 | β |
| Interplay between polygenic propensity for ageing-related traits and the consumption of fruits and vegetables on future dementia diagnosis. | Francis ER et al. | β | 2022 | β |
| Investigation of the causal relationships between human IgG N-glycosylation and 12 common diseases associated with changes in the IgG N-glycome. | Zaytseva OO et al. | β | 2022 | β |
| Life-long dietary restrictions have negligible or damaging effects on late-life cognitive performance: A key role for genetics in outcomes. | Ouellette AR et al. | β | 2022 | β |
| Machine learning methods applied to genotyping data capture interactions between single nucleotide variants in late onset Alzheimer's disease. | Arnal Segura M et al. | β | 2022 | β |
| Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. | Heath L et al. | β | 2022 | β |
| Mapping the gene network landscape of Alzheimer's disease through integrating genomics and transcriptomics. | Rosenthal SB et al. | β | 2022 | β |
| Mapping the genetic landscape of early-onset Alzheimer's disease in a cohort of 36 families. | Mol MO et al. | β | 2022 | β |
| Measuring heritable contributions to Alzheimer's disease: polygenic risk score analysis with twins. | Karlsson IK et al. | β | 2022 | β |
| Mining High-Level Imaging Genetic Associations via Clustering AD Candidate Variants with Similar Brain Association Patterns. | Wu R et al. | β | 2022 | β |
| Mitochondrial Ca<sup>2+</sup> Signaling and Bioenergetics in Alzheimer's Disease. | Arnst N et al. | β | 2022 | β |
| Multi-modal intermediate integrative methods in neuropsychiatric disorders: A review. | Wang Y et al. | β | 2022 | β |
| Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. | Katsumata Y et al. | β | 2022 | β |
| Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. | Gaddis N et al. | β | 2022 | β |
| Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family. | Tejada Moreno JA et al. | β | 2022 | β |
| Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases. | Boyd RJ et al. | β | 2022 | β |
| Neuroinflammatory and Neurometabolomic Consequences From Inhaled Wildfire Smoke-Derived Particulate Matter in the Western United States. | Scieszka D et al. | β | 2022 | β |
| New insights into the genetic etiology of Alzheimer's disease and related dementias. | Bellenguez C et al. | β | 2022 | β |
| Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer's disease. | Wang H et al. | β | 2022 | β |
| Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative Disorders. | Azari A et al. | β | 2022 | β |
| Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification. | Li M et al. | β | 2022 | β |
| Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer's Disease Neuropathology. | Shen WB et al. | β | 2022 | β |
| Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes. | Schramm C et al. | β | 2022 | β |
| PILRA polymorphism modifies the effect of APOE4 and GM17 on Alzheimer's disease risk. | Lopatko Lindman K et al. | β | 2022 | β |
| PLCΞ³2 impacts microglia-related effectors revealing variants and pathways important in Alzheimer's disease. | Li K et al. | β | 2022 | β |
| Polygenic coronary artery disease association with brain atrophy in the cognitively impaired. | de Silva E et al. | β | 2022 | β |
| Polygenic hazard score modified the relationship between hippocampal subfield atrophy and episodic memory in older adults. | Xu J et al. | β | 2022 | β |
| Polygenic resilience scores capture protective genetic effects for Alzheimer's disease. | Hou J et al. | β | 2022 | β |
| Polygenic score for Alzheimer's disease identifies differential atrophy in hippocampal subfield volumes. | Kannappan B et al. | β | 2022 | β |
| Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden. | Ramanan VK et al. | β | 2022 | β |
| Progranulin mutations in clinical and neuropathological Alzheimer's disease. | Vardarajan BN et al. | β | 2022 | β |
| Rare Variant Analysis and Molecular Dynamics Simulation in Alzheimer's Disease Identifies Exonic Variants in FLG. | Xiong W et al. | β | 2022 | β |
| Ras and Rab Interactor 3: From Cellular Mechanisms to Human Diseases. | Shen R et al. | β | 2022 | β |
| Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer's disease-associated genes: DTNB and DLG2. | Prokopenko D et al. | β | 2022 | β |
| Sleep duration, genetic susceptibility, and Alzheimer's disease: a longitudinal UK Biobank-based study. | Yuan S et al. | β | 2022 | β |
| Systemic hormone therapy and dementia: A nested case-control and co-twin control study. | LΓΈkkegaard LE et al. | β | 2022 | β |
| The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects. | Lambert E et al. | β | 2022 | β |
| The Association between TREM2 Gene and Late-Onset Alzheimer's Disease in Chinese Han Population. | Sun Y et al. | β | 2022 | β |
| The heritability of amyloid burden in older adults: the Older Australian Twins Study. | Koncz R et al. | β | 2022 | β |
| The impact of genetic risk for Alzheimer's disease on the structural brain networks of young adults. | Mirza-Davies A et al. | β | 2022 | β |
| The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases. | Sundaramoorthy TH et al. | β | 2022 | β |
| The Neuropsychiatric Approach to the Assessment of Patients in Neurology. | Trapp NT et al. | β | 2022 | β |
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. | Frisoni GB et al. | β | 2022 | β |
| Therapeutic Potential of Astrocyte Transplantation. | Hastings N et al. | β | 2022 | β |
| The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease. | Bossaerts L et al. | β | 2022 | β |
| The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review. | Aaldijk E et al. | β | 2022 | β |
| The role of structural variations in Alzheimer's disease and other neurodegenerative diseases. | Wang H et al. | β | 2022 | β |
| Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related Phenotypes. | Jung SH et al. | β | 2022 | β |
| Trauma-like exposure alters neuronal apoptosis, Bin1, Fkbp5 and NR2B expression in an amyloid-beta (1-42) rat model of Alzheimer's disease. | Faborode OS et al. | β | 2022 | β |
| Understanding the contributions of VPS35 and the retromer in neurodegenerative disease. | Williams ET et al. | β | 2022 | β |
| Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations. | Motazedi E et al. | β | 2022 | β |
| Variant TREM2 Signaling in Alzheimer's Disease. | Olufunmilayo EO et al. | β | 2022 | β |
| What contribution can genetics make to predict the risk of Alzheimer's disease? | Schramm C et al. | β | 2022 | β |
| Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease. | Ming C et al. | β | 2022 | β |
| Whole-genome sequencing reveals novel ethnicity-specific rare variants associated with Alzheimer's disease. | Shigemizu D et al. | β | 2022 | β |
| Willin/FRMD6 Mediates Mitochondrial Dysfunction Relevant to Neuronal AΞ² Toxicity. | Chen D et al. | β | 2022 | β |
| Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics. | Horimoto ARVR et al. | β | 2021 | β |
| Advances in Genetics and Epigenetic Alterations in Alzheimer's Disease: A Notion for Therapeutic Treatment. | Rabaneda-Bueno R et al. | β | 2021 | β |
| A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. | Wightman DP et al. | β | 2021 | β |
| Alzheimer's disease. | Scheltens P et al. | β | 2021 | β |
| Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans. | Ferguson SA et al. | β | 2021 | β |
| Alzheimer's disease genetic risk and sleep phenotypes in healthy young men: association with more slow waves and daytime sleepiness. | Muto V et al. | β | 2021 | β |
| A Machine Learning Method to Identify Genetic Variants Potentially Associated With Alzheimer's Disease. | Monk B et al. | β | 2021 | β |
| A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages. | Park JY et al. | β | 2021 | β |
| A novel age-informed approach for genetic association analysis in Alzheimer's disease. | Le Guen Y et al. | β | 2021 | β |
| A novel missense variant in ACAA1 contributes to early-onset Alzheimer's disease, impairs lysosomal function, and facilitates amyloid-Ξ² pathology and cognitive decline. | Luo R et al. | β | 2021 | β |
| A penalized structural equation modeling method accounting for secondary phenotypes for variable selection on genetically regulated expression from PrediXcan for Alzheimer's disease. | Chen TH et al. | β | 2021 | β |
| Apolipoprotein E homozygous Ξ΅4 allele status: Effects on cortical structure and white matter integrity in a young to mid-age sample. | Goltermann J et al. | β | 2021 | β |
| A Review of the Current Mammalian Models of Alzheimer's Disease and Challenges That Need to Be Overcome. | Mckean NE et al. | β | 2021 | β |
| Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease. | Handy A et al. | β | 2021 | β |
| Association and Gene-Gene Interactions Study of Late-Onset Alzheimer's Disease in the Russian Population. | Bocharova A et al. | β | 2021 | β |
| Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum. | Nilsson NIV et al. | β | 2021 | β |
| Associations of Alzheimer's disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration. | Tan MS et al. | β | 2021 | β |
| Body Mass Index and Polygenic Risk for Alzheimer's Disease Predict Conversion to Alzheimer's Disease. | Moody JN et al. | β | 2021 | β |
| Careful feature selection is key in classification of Alzheimer's disease patients based on whole-genome sequencing data. | Osipowicz M et al. | β | 2021 | β |
| Causal association of cognitive reserve on Alzheimer's disease with putative sex difference. | Wang H et al. | β | 2021 | β |
| Changes in retinal microvasculature and retinal layer thickness in association with apolipoprotein E genotype in Alzheimer's disease. | Shin JY et al. | β | 2021 | β |
| Circadian changes in Alzheimer's disease: Neurobiology, clinical problems, and therapeutic opportunities. | Toljan K et al. | β | 2021 | β |
| Clinical Insights into Mitochondrial Neurodevelopmental and Neurodegenerative Disorders: Their Biosignatures from Mass Spectrometry-Based Metabolomics. | Li H et al. | β | 2021 | β |
| Convergent lines of evidence support BIN1 as a risk gene of Alzheimer's disease. | Zhu J et al. | β | 2021 | β |
| Cumulative Genetic Risk and <i>APOE Ξ΅4</i> Are Independently Associated With Dementia Status in a Multiethnic, Population-Based Cohort. | Bakulski KM et al. | β | 2021 | β |
| Different Age Related Neurological and Cardiac Effects of Verapamil on a Transgenic Mouse Model of Alzheimer's Disease. | Cojocaru A et al. | β | 2021 | β |
| Dissecting the role of Amerindian genetic ancestry and the ApoE Ξ΅4 allele on Alzheimer disease in an admixed Peruvian population. | Marca-Ysabel MV et al. | β | 2021 | β |
| Down-regulation of SORL1 is associated with Alzheimer's disease through activating ABC transporter pathway. | Wei Z et al. | β | 2021 | β |
| Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-Ξ² deposition in Alzheimer's disease. | Park YH et al. | β | 2021 | β |
| Early-Onset Alzheimer's Disease: What Is Missing in Research? | Ayodele T et al. | β | 2021 | β |
| Editorial: Genetics of Age-Related Diseases and Their Risk and Protective Factors. | Karlsson IK et al. | β | 2021 | β |
| Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease risk. | Shigemizu D et al. | β | 2021 | β |
| Frailty and the risk of dementia: is the association explained by shared environmental and genetic factors? | Bai G et al. | β | 2021 | β |
| Functional co-activation of the default mode network in APOE Ξ΅4-carriers: A replication study. | Mentink LJ et al. | β | 2021 | β |
| Genetic contributions to bipolar disorder: current status and future directions. | O'Connell KS et al. | β | 2021 | β |
| Genetic Insights into the Impact of Complement in Alzheimer's Disease. | Torvell M et al. | β | 2021 | β |
| Genetic predisposition, AΞ² misfolding in blood plasma, and Alzheimer's disease. | Stocker H et al. | β | 2021 | β |
| Genetics of Alzheimer's disease. | KΓΆnig T et al. | β | 2021 | β |
| Genetic underpinnings of sociability in the general population. | Bralten J et al. | β | 2021 | β |
| Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries: A Systematic Review. | Al-Thani HF et al. | β | 2021 | β |
| Genome-wide epistasis analysis for Alzheimer's disease and implications for genetic risk prediction. | Wang H et al. | β | 2021 | β |
| GenoRisk: A polygenic risk score for Alzheimer's disease. | Dickson SP et al. | β | 2021 | β |
| Glaucoma as Neurodegeneration in the Brain. | Chan JW et al. | β | 2021 | β |
| Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-Ξ΅4 carriers. | Fulton-Howard B et al. | β | 2021 | β |
| Harpertrioate A, an A,B,D-<i>seco</i>-Limonoid with Promising Biological Activity against Alzheimer's Disease from Twigs of <i>Harrisonia perforata</i> (Blanco) Merr. | Tang XH et al. | β | 2021 | β |
| Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer's disease. | Liu N et al. | β | 2021 | β |
| How understudied populations have contributed to our understanding of Alzheimer's disease genetics. | Dehghani N et al. | β | 2021 | β |
| Identifying novel genetic variants for brain amyloid deposition: a genome-wide association study in the Korean population. | Kim HR et al. | β | 2021 | β |
| Inhibitory FcΞ³ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease. | Pandey JP et al. | β | 2021 | β |
| InTACT: An adaptive and powerful framework for joint-tissue transcriptome-wide association studies. | Bae YE et al. | β | 2021 | β |
| Large-scale sequencing studies expand the known genetic architecture of Alzheimer's disease. | Xue D et al. | β | 2021 | β |
| Longitudinal analysis of <i>APOE-Ι4</i> genotype with the logical memory delayed recall score in Alzheimer's disease. | Fokuoh E et al. | β | 2021 | β |
| Long-Term Sex- and Genotype-Specific Effects of <sup>56</sup>Fe Irradiation on Wild-Type and APPswe/PS1dE9 Transgenic Mice. | Schroeder MK et al. | β | 2021 | β |
| Mechanisms of Metal-Induced Mitochondrial Dysfunction in Neurological Disorders. | Cheng H et al. | β | 2021 | β |
| Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. | Nabais MF et al. | β | 2021 | β |
| Missing <i>lnc</i>(RNAs) in Alzheimer's Disease? | Policarpo R et al. | β | 2021 | β |
| Mitochondria-associated endoplasmic reticulum membranes: At the crossroad between familiar and sporadic Alzheimer's disease. | Wang K et al. | β | 2021 | β |
| Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease. | Paliwal D et al. | β | 2021 | β |
| Molecular Genetics of Early- and Late-Onset Alzheimer's Disease. | Uddin MS et al. | β | 2021 | β |
| Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies. | Kaur D et al. | β | 2021 | β |
| Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease. | Murray AN et al. | β | 2021 | β |
| Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. | Kunkle BW et al. | β | 2021 | β |
| Novel Alzheimer's disease risk variants identified based on whole-genome sequencing of APOE Ξ΅4 carriers. | Park JH et al. | β | 2021 | β |
| Onset of Preclinical Alzheimer Disease in Monozygotic Twins. | Konijnenberg E et al. | β | 2021 | β |
| Pathobiolgy and Management of Alzheimer's Disease. | Kim H et al. | β | 2021 | β |
| Pharmacogenetic and Association Studies on the Influence of HLA Alleles and Rivastigmine on the Iranian Patients with Late-Onset Alzheimer's Disease. | Rezaei Rad F et al. | β | 2021 | β |
| Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration. | Ernest James Phillips T et al. | β | 2021 | β |
| PIP2 depletion and altered endocytosis caused by expression of Alzheimer's disease-protective variant PLCΞ³2 R522. | Maguire E et al. | β | 2021 | β |
| Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease. | Daunt P et al. | β | 2021 | β |
| Polygenic Score Models for Alzheimer's Disease: From Research to Clinical Applications. | Zhou X et al. | β | 2021 | β |
| Polymorphism rs11867353 of Tyrosine Kinase Non-Receptor 1 (TNK1) Gene Is a Novel Genetic Marker for Alzheimer's Disease. | Zeman T et al. | β | 2021 | β |
| Predictability of polygenic risk score for progression to dementia and its interaction with APOE Ξ΅4 in mild cognitive impairment. | Pyun JM et al. | β | 2021 | β |
| Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohortΒ prospectively followed over 17 years. | Stocker H et al. | β | 2021 | β |
| Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases. | Akter R et al. | β | 2021 | β |
| Protective genes and pathways in Alzheimer's disease: moving towards precision interventions. | Seto M et al. | β | 2021 | β |
| Psychiatry in the Digital Age: A Blessing or a Curse? | Roth CB et al. | β | 2021 | β |
| Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models. | Gurdon B et al. | β | 2021 | β |
| Rare variants in the endocytic pathway are associated with Alzheimer's disease, its related phenotypes, and functional consequences. | Zhan L et al. | β | 2021 | β |
| Risk of neurodegenerative disease due to tau phosphorylation changes and arsenic exposure via drinking water. | Pakzad D et al. | β | 2021 | β |
| Roles of Microglial Ion Channel in Neurodegenerative Diseases. | Cojocaru A et al. | β | 2021 | β |
| Searching the Dark Genome for Alzheimer's Disease Risk Variants. | Raybould R et al. | β | 2021 | β |
| Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants. | Patel D et al. | β | 2021 | β |
| Synergistic Effects of APOE and CLU May Increase the Risk of Alzheimer's Disease: Acceleration of Atrophy in the Volumes and Shapes of the Hippocampus and Amygdala. | An N et al. | β | 2021 | β |
| Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies. | Miyoshi E et al. | β | 2021 | β |
| The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer's Disease. | Bellver-Sanchis A et al. | β | 2021 | β |
| The Effect of Alzheimer's Disease-Associated Genetic Variants on Longevity. | Tesi N et al. | β | 2021 | β |
| The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease. | Gao P et al. | β | 2021 | β |
| The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer's disease: A systematic review and meta-analysis. | Li R et al. | β | 2021 | β |
| The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation. | Benoit SL et al. | β | 2021 | β |
| The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models. | MacDougall G et al. | β | 2021 | β |
| The Potential Role of Herpes Simplex Virus Type 1 and Neuroinflammation in the Pathogenesis of Alzheimer's Disease. | Laval K et al. | β | 2021 | β |
| The Role of AhR in the Hallmarks of Brain Aging: Friend and Foe. | Ojo ES et al. | β | 2021 | β |
| The transcriptional landscape of Alzheimer's disease and its association with Wnt signaling pathway. | MartΓnez M et al. | β | 2021 | β |
| Transcriptional downregulation of FAM3C/ILEI in the Alzheimer's brain. | Watanabe N et al. | β | 2021 | β |
| ABCA7 and EphA1 Genes Polymorphisms in Late-Onset Alzheimer's Disease. | Talebi M et al. | β | 2020 | β |
| A comprehensive analysis of methods for assessing polygenic burden on Alzheimer's disease pathology and risk beyond <i>APOE</i>. | Altmann A et al. | β | 2020 | β |
| Age-dependent effect of APOE and polygenic component on Alzheimer's disease. | Bellou E et al. | β | 2020 | β |
| Age-dependent effects of body mass index across the adult life span on the risk of dementia: a cohort study with a genetic approach. | Karlsson IK et al. | β | 2020 | β |
| Alzheimer Disease Pathology-Associated Polymorphism in a Complex Variable Number of Tandem Repeat Region Within the MUC6 Gene, Near the AP2A2 Gene. | Katsumata Y et al. | β | 2020 | β |
| Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? | Mullane K et al. | β | 2020 | β |
| Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (Nβ=β395,769). | Ferguson AC et al. | β | 2020 | β |
| Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis. | Ando K et al. | β | 2020 | β |
| A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap. | Badhwar A et al. | β | 2020 | β |
| An Overview of Astrocyte Responses in Genetically Induced Alzheimer's Disease Mouse Models. | Spanos F et al. | β | 2020 | β |
| An update on human astrocytes and their role in development and disease. | de Majo M et al. | β | 2020 | β |
| A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2. | Karsak M et al. | β | 2020 | β |
| Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese Cohort. | Li WW et al. | β | 2020 | β |
| A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases. | Soyal SM et al. | β | 2020 | β |
| A Twin Study of Sex Differences in Genetic Risk for All Dementia, Alzheimer's Disease (AD), and Non-AD Dementia. | Beam CR et al. | β | 2020 | β |
| AΞ²-accelerated neurodegeneration caused by Alzheimer's-associated <i>ACE</i> variant R1279Q is rescued by angiotensin system inhibition in mice. | Cuddy LK et al. | β | 2020 | β |
| Beyond SNP heritability: Polygenicity and discoverability of phenotypes estimated with a univariate Gaussian mixture model. | Holland D et al. | β | 2020 | β |
| Biological and environmental predictors of heterogeneity in neurocognitive ageing: Evidence from Betula and other longitudinal studies. | Nyberg L et al. | β | 2020 | β |
| Blood Transcriptome Response to Environmental Metal Exposure Reveals Potential Biological Processes Related to Alzheimer's Disease. | Krauskopf J et al. | β | 2020 | β |
| Body mass index is associated with smaller medial temporal lobe volume in those at risk for Alzheimer's disease. | Hayes JP et al. | β | 2020 | β |
| Chronic copper exposure directs microglia towards degenerative expression signatures in wild-type and J20 mouse model of Alzheimer's disease. | Lim SL et al. | β | 2020 | β |
| Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study. | Ware EB et al. | β | 2020 | β |
| Education and Cognitive Functioning Across the Life Span. | LΓΆvdΓ©n M et al. | β | 2020 | β |
| Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging. | Kauppi K et al. | β | 2020 | β |
| Ethnic Differences in Attending a Tertiary Dementia Clinic in Israel. | Specktor P et al. | β | 2020 | β |
| Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer's Disease. | Kabir MT et al. | β | 2020 | β |
| Familial risk of dementia and mediators of memory clinic referrals. | Haussmann R et al. | β | 2020 | β |
| Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. | Griciuc A et al. | β | 2020 | β |
| Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population. | Zhou X et al. | β | 2020 | β |
| Genetic architecture of common non-Alzheimer's disease dementias. | Guerreiro R et al. | β | 2020 | β |
| Genetic architecture of neurodegenerative dementias. | Clarimon J et al. | β | 2020 | β |
| Genetic Association of FERMT2, HLA-DRB1, CD2AP, and PTK2B Polymorphisms With Alzheimer's Disease Risk in the Southern Chinese Population. | Yan Y et al. | β | 2020 | β |
| Genetic associations of in vivo pathology influence Alzheimer's disease susceptibility. | Seo J et al. | β | 2020 | β |
| Genetic Dissection of Alzheimer's Disease Using <i>Drosophila</i> Models. | Jeon Y et al. | β | 2020 | β |
| Genetic influence on ageing-related changes in resting-state brain functional networks in healthy adults: A systematic review. | Foo H et al. | β | 2020 | β |
| Genetic risk for Alzheimer disease in children: Evidence from early-life IQ and brain white-matter microstructure. | Vinueza-Veloz MF et al. | β | 2020 | β |
| Genetic risk for Alzheimer's disease influences neuropathology via multiple biological pathways. | Hannon E et al. | β | 2020 | β |
| Genetic Risk for Alzheimer's Disease Moderates the Association Between Medial Temporal Lobe Volume and Episodic Memory Performance Among Older Adults. | Prieto S et al. | β | 2020 | β |
| Genetics of Alzheimer's disease: where we are, and where we are going. | Bellenguez C et al. | β | 2020 | β |
| Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset. | Hong S et al. | β | 2020 | β |
| Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease. | Wang H et al. | β | 2020 | β |
| Gold Nanoparticles Crossing Blood-Brain Barrier Prevent HSV-1 Infection and Reduce Herpes Associated Amyloid-Ξ²secretion. | I RI et al. | β | 2020 | β |
| Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population. | Zhao J et al. | β | 2020 | β |
| Haplotype architecture of the Alzheimer's risk in the <i>APOE</i> region via co-skewness. | Kulminski AM et al. | β | 2020 | β |
| Heavy Metals Exposure and Alzheimer's Disease and Related Dementias. | Bakulski KM et al. | β | 2020 | β |
| Identification of Methylated Gene Biomarkers in Patients with Alzheimer's Disease Based on Machine Learning. | Ren J et al. | β | 2020 | β |
| Identification of Novel Genes Associated with Cortical Thickness in Alzheimer's Disease: Systems Biology Approach to Neuroimaging Endophenotype. | Kim BH et al. | β | 2020 | β |
| Imaging Alzheimer's genetic risk using diffusion MRI: A systematic review. | Harrison JR et al. | β | 2020 | β |
| Imaging genomics discovery of a new risk variant for Alzheimer's disease in the postsynaptic SHARPIN gene. | Soheili-Nezhad S et al. | β | 2020 | β |
| Immune and Inflammatory Pathways Implicated by Whole Blood Transcriptomic Analysis in a Diverse Ancestry Alzheimer's Disease Cohort. | Griswold AJ et al. | β | 2020 | β |
| Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories. | Lopresti BJ et al. | β | 2020 | β |
| Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease. | PerdigΓ£o C et al. | β | 2020 | β |
| Invited Review - A 5-year update on epigenome-wide association studies of DNA modifications in Alzheimer's disease: progress, practicalities and promise. | Smith AR et al. | β | 2020 | β |
| MicroRNA-138 Overexpression Alters AΞ²42 Levels and Behavior in Wildtype Mice. | Boscher E et al. | β | 2020 | β |
| Missing heritability of complex diseases: case solved? | GΓ©nin E | β | 2020 | β |
| Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease. | Guo T et al. | β | 2020 | β |
| MRI-visible dilated perivascular spaces in healthy young adults: A twin heritability study. | Choi Y et al. | β | 2020 | β |
| Novel Alzheimer risk genes determine the microglia response to amyloid-Ξ² but not to TAU pathology. | Sierksma A et al. | β | 2020 | β |
| Polygenic risk and pleiotropy in neurodegenerative diseases. | Bellou E et al. | β | 2020 | β |
| Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease. | Strianese O et al. | β | 2020 | β |
| Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data. | Shigemizu D et al. | β | 2020 | β |
| Psychosis in Alzheimer's Disease. | Ballard C et al. | β | 2020 | β |
| Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture. | Zhang Q et al. | β | 2020 | β |
| Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. | Fan CC et al. | β | 2020 | β |
| Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease. | Tatiparti K et al. | β | 2020 | β |
| Stroke and Alzheimer's Disease: A Mendelian Randomization Study. | Wang T et al. | β | 2020 | β |
| The Application of Artificial Intelligence in the Genetic Study of Alzheimer's Disease. | Mishra R et al. | β | 2020 | β |
| [The future of dementia prevention and treatment strategies]. | β | β | 2020 | β |
| The Genetics of Alzheimer's Disease in the Chinese Population. | Gan CL et al. | β | 2020 | β |
| The genetics of human ageing. | Melzer D et al. | β | 2020 | β |
| The impact of disregarding family structure on genome-wide association analysis of complex diseases in cohorts with simple pedigrees. | Nazarian A et al. | β | 2020 | β |
| The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics. | Ravona-Springer R et al. | β | 2020 | β |
| The MUC6/AP2A2 Locus and Its Relevance toΒ Alzheimer's Disease: A Review. | Nelson PT et al. | β | 2020 | β |
| The multiplex model of the genetics of Alzheimer's disease. | Sims R et al. | β | 2020 | β |
| The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling. | Lee C et al. | β | 2020 | β |
| Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets. | Sierksma A et al. | β | 2020 | β |
| Understanding Alzheimer's disease through the genetics of sleep. | Lee EE | β | 2020 | β |
| Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | Shen R et al. | β | 2020 | β |
| Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers. | Fan KH et al. | β | 2020 | β |
| Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation. | Bis JC et al. | β | 2020 | β |
| A Brief Review of Paradigm Shifts in Prevention of Alzheimer's Disease: From Cognitive Reserve to Precision Medicine. | Hahn C et al. | β | 2019 | β |
| A functional variant in the miR-142 promoter modulating its expression and conferring risk of Alzheimer disease. | Ghanbari M et al. | β | 2019 | β |
| Age-related late-onset disease heritability patterns and implications for genome-wide association studies. | Oliynyk RT | β | 2019 | β |
| Alzheimer's disease. | Soria Lopez JA et al. | β | 2019 | β |
| Alzheimer's disease: A clinical perspective and future nonhuman primate research opportunities. | Haque RU et al. | β | 2019 | β |
| Alzheimer's disease as a multistage process: an analysis from a population-based cohort study. | Licher S et al. | β | 2019 | β |
| Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. | Magno L et al. | β | 2019 | β |
| Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment. | Chaudhury S et al. | β | 2019 | β |
| A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease. | Asanomi Y et al. | β | 2019 | β |
| A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease. | Zhang X et al. | β | 2019 | β |
| Association of PPP2R1A with Alzheimer's disease and specific cognitive domains. | Miron J et al. | β | 2019 | β |
| Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry. | Patel D et al. | β | 2019 | β |
| Benefits and Challenges of Rare Genetic Variation in Alzheimer's Disease. | Grozeva D et al. | β | 2019 | β |
| BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr<sup>348</sup> phosphorylation. | Sartori M et al. | β | 2019 | β |
| Centenarian controls increase variant effect sizes by an average twofold in an extreme case-extreme control analysis of Alzheimer's disease. | Tesi N et al. | β | 2019 | β |
| Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies. | Foster EM et al. | β | 2019 | β |
| Copper-Induced Upregulation of MicroRNAs Directs the Suppression of Endothelial LRP1 in Alzheimer's Disease Model. | Hsu HW et al. | β | 2019 | β |
| Copy Number Variants in miR-138 as a Potential Risk Factor for Early-Onset Alzheimer's Disease. | Boscher E et al. | β | 2019 | β |
| Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders. | Espinosa-Parrilla Y et al. | β | 2019 | β |
| Diabetes and Alzheimer's Disease: A Link not as Simple as it Seems. | Salas IH et al. | β | 2019 | β |
| Dopaminergic gene methylation is associated with cognitive performance in a childhood monozygotic twin study. | Lewis CR et al. | β | 2019 | β |
| Dysfunction of mitochondria: Implications for Alzheimer's disease. | Albensi BC | β | 2019 | β |
| Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases. | McAlary L et al. | β | 2019 | β |
| Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases. | Rana P et al. | β | 2019 | β |
| Evaluation of the Genetic Variance of Alzheimer's Disease Explained by the Disease-Associated Chromosomal Regions. | Nazarian A et al. | β | 2019 | β |
| Friend, Foe or Both? Immune Activity in Alzheimer's Disease. | Frost GR et al. | β | 2019 | β |
| Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease. | Baker E et al. | β | 2019 | β |
| Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease. | Dunn AR et al. | β | 2019 | β |
| Genetic Analyses of Alzheimer's Disease in China: Achievements and Perspectives. | Zhang DF et al. | β | 2019 | β |
| Genetic Interaction of <i>APOE</i> and <i>FGF1</i> is Associated with Memory Impairment and Hippocampal Atrophy in Alzheimer's Disease. | Chang YT et al. | β | 2019 | β |
| Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates AΞ², tau, immunity and lipid processing. | Kunkle BW et al. | β | 2019 | β |
| Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes. | Drange OK et al. | β | 2019 | β |
| Genetic risk for coronary heart disease alters the influence of Alzheimer's genetic risk on mild cognitive impairment. | Elman JA et al. | β | 2019 | β |
| Genetic Study of Alzheimer's Disease in Saudi Population. | El Bitar F et al. | β | 2019 | β |
| Genetic Variants of <i>PICALM</i> rs541458 Modulate Brain Spontaneous Activity in Older Adults With Amnestic Mild Cognitive Impairment. | Zhuang L et al. | β | 2019 | β |
| Genome-wide analysis of genetic predisposition to Alzheimer's disease and related sex disparities. | Nazarian A et al. | β | 2019 | β |
| Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. | Jansen IE et al. | β | 2019 | β |
| History and progress of hypotheses and clinical trials for Alzheimer's disease. | Liu PP et al. | β | 2019 | β |
| Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease? | Hegde V et al. | β | 2019 | β |
| Identification of genetic heterogeneity of Alzheimer's disease across age. | Lo MT et al. | β | 2019 | β |
| Immediate verbal recall and familial dementia risk: population-based study of over 4000 twins. | Lindgren N et al. | β | 2019 | β |
| Lipid class composition of membrane and raft fractions from brains of individuals with Alzheimer's disease. | Kawatsuki A et al. | β | 2019 | β |
| Lipid metabolism in Alzheimer's disease. | Zhu TB et al. | β | 2019 | β |
| Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics. | Blue EE et al. | β | 2019 | β |
| Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription. | Suh J et al. | β | 2019 | β |
| <i>Complement C7</i> is a novel risk gene for Alzheimer's disease in Han Chinese. | Zhang DF et al. | β | 2019 | β |
| New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases. | Maniati MS et al. | β | 2019 | β |
| New molecular approaches to Alzheimer's disease. | Di Resta C et al. | β | 2019 | β |
| On the Fly: Recent Progress on Autophagy and Aging in Drosophila. | Maruzs T et al. | β | 2019 | β |
| Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases. | Htike TT et al. | β | 2019 | β |
| Peripheral blood DNA methylation differences in twin pairs discordant for Alzheimer's disease. | Konki M et al. | β | 2019 | β |
| Polygenic risk and hazard scores for Alzheimer's disease prediction. | Leonenko G et al. | β | 2019 | β |
| Prediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers. | Gupta Y et al. | β | 2019 | β |
| Promoter DNA hypermethylation - Implications for Alzheimer's disease. | Liu Y et al. | β | 2019 | β |
| Shared genetic architecture between metabolic traits and Alzheimer's disease: a large-scale genome-wide cross-trait analysis. | Zhu Z et al. | β | 2019 | β |
| Synaptic Elimination in Neurological Disorders. | Cardozo PL et al. | β | 2019 | β |
| The Alzheimer's Disease Exposome. | Finch CE et al. | β | 2019 | β |
| The C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and Susceptibility to Late-onset Alzheimer's Disease. | Yi J et al. | β | 2019 | β |
| The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk. | Fan J et al. | β | 2019 | β |
| The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis? | Dourlen P et al. | β | 2019 | β |
| The role of de novo mutations in adult-onset neurodegenerative disorders. | Nicolas G et al. | β | 2019 | β |
| The Swedish Twin Registry: Content and Management as a Research Infrastructure. | Zagai U et al. | β | 2019 | β |
| The X Files: "The Mystery of X Chromosome Instability in Alzheimer's Disease". | Bajic VP et al. | β | 2019 | β |
| Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's disease. | Dalmasso MC et al. | β | 2019 | β |
| ABCA7 and Pathogenic Pathways of Alzheimer's Disease. | Aikawa T et al. | β | 2018 | β |
| Aberrant DNA methylation associated with Alzheimer's disease in the superior temporal gyrus. | Gao Z et al. | β | 2018 | β |
| A Brief Synopsis on the Genetics of Alzheimer's Disease. | Kamboh MI | β | 2018 | β |
| A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. | Lacher SE et al. | β | 2018 | β |
| Alzheimer Disease: Perspectives from Epidemiology and Genetics. | Haines JL | β | 2018 | β |
| Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+). | MΓ€kelΓ€ M et al. | β | 2018 | β |
| Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis. | Eratne D et al. | β | 2018 | β |
| Alzheimer's disease DNA methylome of pyramidal layers in frontal cortex: laser-assisted microdissection study. | HernΓ‘ndez HG et al. | β | 2018 | β |
| Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP. | Nafikov RA et al. | β | 2018 | β |
| Analysis of PTPRK polymorphisms in association with risk and age at onset of Alzheimer's disease, cancer risk, and cholesterol. | Chen Y et al. | β | 2018 | β |
| An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk. | Rao S et al. | β | 2018 | β |
| A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1β+βPICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEΙ4 Carriers. | Sapkota S et al. | β | 2018 | β |
| An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease. | De Roeck A et al. | β | 2018 | β |
| Another Round of "Clue" to Uncover the Mystery of Complex Traits. | Verma SS et al. | β | 2018 | β |
| A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress. | Hoeijmakers L et al. | β | 2018 | β |
| Association of glutathione S-transferases M1, P1 and T1 variations and risk of late-onset Alzheimer's disease. | Jafarian Z et al. | β | 2018 | β |
| Association of GPX1 and GPX4 polymorphisms with episodic memory and Alzheimer's disease. | da Rocha TJ et al. | β | 2018 | β |
| Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort. | BabiΔ Leko M et al. | β | 2018 | β |
| At the Crossroads Between Neurodegeneration and Cancer: A Review of Overlapping Biology and Its Implications. | Houck AL et al. | β | 2018 | β |
| Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease. | Vogel JW et al. | β | 2018 | β |
| Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. | Lewczuk P et al. | β | 2018 | β |
| Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression? | Italiani P et al. | β | 2018 | β |
| Combined application of tenuigenin and Ξ²-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer's disease. | Chang W et al. | β | 2018 | β |
| Common Variants in <i>PLXNA4</i> and Correlation to CSF-related Phenotypes in Alzheimer's Disease. | Han Q et al. | β | 2018 | β |
| Cross Talk Between Aluminum and Genetic Susceptibility and Epigenetic Modification in Alzheimer's Disease. | Liang R | β | 2018 | β |
| Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study. | Ahmad S et al. | β | 2018 | β |
| Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease. | Xu W et al. | β | 2018 | β |
| Early-Onset Alzheimer Disease (EOAD) With Aphasia: A Case Report. | Borges MK et al. | β | 2018 | β |
| Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort. | Scholz CJ et al. | β | 2018 | β |
| Genetic and genomic testing for neurologic disease in clinical practice. | Fogel BL | β | 2018 | β |
| Genetic Risks for Chronic Conditions: Implications for Long-term Wellbeing. | Wehby GL et al. | β | 2018 | β |
| Genetics of dementia in a Finnish cohort. | Pasanen P et al. | β | 2018 | β |
| Lack of association between triggering receptor expressed on myeloid cells 2 polymorphism rs75932628 and late-onset Alzheimer's disease in a Chinese Han population. | Wang P et al. | β | 2018 | β |
| Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer's disease. | Grace C et al. | β | 2018 | β |
| Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease. | Gusareva ES et al. | β | 2018 | β |
| Meta-analysis of the association between <i>CD33</i> and Alzheimer's disease. | Jiang YT et al. | β | 2018 | β |
| Microglia in Alzheimer's Disease: A Role for Ion Channels. | Thei L et al. | β | 2018 | β |
| Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease. | Onyango IG | β | 2018 | β |
| Neurotransmitter Pathway Genes in Cognitive Decline During Aging: Evidence for GNG4 and KCNQ2 Genes. | Bonham LW et al. | β | 2018 | β |
| New insights into the role of TREM2 in Alzheimer's disease. | Gratuze M et al. | β | 2018 | β |
| Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: A focus on human studies. | Pistollato F et al. | β | 2018 | β |
| Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease. | Feng L et al. | β | 2018 | β |
| Polygenic Risk Score for Alzheimer's Disease: Implications for Memory Performance and Hippocampal Volumes in Early Life. | Axelrud LK et al. | β | 2018 | β |
| Prediction of Alzheimer's Disease-Associated Genes by Integration of GWAS Summary Data and Expression Data. | Hao S et al. | β | 2018 | β |
| Prion-like mechanisms in Alzheimer disease. | Walker LC | β | 2018 | β |
| Proximity to Parental Symptom Onset and Amyloid-Ξ² Burden in Sporadic Alzheimer Disease. | Villeneuve S et al. | β | 2018 | β |
| Sexual dimorphism in predisposition to Alzheimer's disease. | Fisher DW et al. | β | 2018 | β |
| Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks. | Arneson D et al. | β | 2018 | β |
| Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. | Young JE et al. | β | 2018 | β |
| Stem Cells and Other Emerging Agents as Innovative "Drugs" in Neurodegenerative Diseases: Benefits and Limitations. | Nasello M et al. | β | 2018 | β |
| Suppression of Presymptomatic Oxidative Stress and Inflammation in Neurodegeneration by Grape-Derived Polyphenols. | Herman F et al. | β | 2018 | β |
| Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism. | Yi D et al. | β | 2018 | β |
| The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study. | van der Lee SJ et al. | β | 2018 | β |
| The emerging risk of exposure to air pollution onΒ cognitive decline and Alzheimer's disease - Evidence from epidemiological and animal studies. | Kilian J et al. | β | 2018 | β |
| The EMIF-AD PreclinAD study: study design and baseline cohort overview. | Konijnenberg E et al. | β | 2018 | β |
| The genes associated with early-onset Alzheimer's disease. | Dai MH et al. | β | 2018 | β |
| The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives. | GarcΓa JC et al. | β | 2018 | β |
| The genetic landscape of Alzheimer disease. | Carmona S et al. | β | 2018 | β |
| The genetic risk of Alzheimer's disease beyond APOE Ξ΅4: systematic review of Alzheimer's genetic risk scores. | Stocker H et al. | β | 2018 | β |
| The GWAS Risk Genes for Depression May Be Actively Involved in Alzheimer's Disease. | Ni H et al. | β | 2018 | β |
| The personal and clinical utility of polygenic risk scores. | Torkamani A et al. | β | 2018 | β |
| The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review. | Freudenberg-Hua Y et al. | β | 2018 | β |
| Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? | Deming Y et al. | β | 2018 | β |
| Untangling Genetic Risk for Alzheimer's Disease. | Pimenova AA et al. | β | 2018 | β |
| Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. | Porter T et al. | β | 2018 | β |
| Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology. | Hajipour MJ et al. | β | 2017 | β |
| Alzheimer disease. | Calderon-GarcidueΓ±as AL et al. | β | 2017 | β |
| Alzheimer Disease: Scientific Breakthroughs and Translational Challenges. | Caselli RJ et al. | β | 2017 | β |
| Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach. | Hu YS et al. | β | 2017 | β |
| APOE and KIBRA Interactions on Brain Functional Connectivity in Healthy Young Adults. | Zhang N et al. | β | 2017 | β |
| Association of GWAS Top Genes With Late-Onset Alzheimer's Disease in Colombian Population. | Moreno DJ et al. | β | 2017 | β |
| Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis. | Lu RC et al. | β | 2017 | β |
| Bayesian Cox Proportional Hazards Model in Survival Analysis of HACE1 Gene with Age at Onset of Alzheimer's Disease. | Wang KS et al. | β | 2017 | β |
| Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. | Holstege H et al. | β | 2017 | β |
| Cognitive ability in young adulthood and risk of dementia in a cohort of Danish men, brothers, and twins. | Osler M et al. | β | 2017 | β |
| Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls. | Bellenguez C et al. | β | 2017 | β |
| Copy Number Variants in Alzheimer's Disease. | Cuccaro D et al. | β | 2017 | β |
| Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport. | Kunkle BW et al. | β | 2017 | β |
| Effect of APOE Ξ΅4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease. | Morris JK et al. | β | 2017 | β |
| Effect of CLU and PICALM polymorphisms on AD risk: A study from south India. | Shankarappa BM et al. | β | 2017 | β |
| Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease? | Whyte LS et al. | β | 2017 | β |
| Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function. | Cukier HN et al. | β | 2017 | β |
| Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease. | Wang KS et al. | β | 2017 | β |
| Gene- gene interaction between CYP2J2 and PPAR -Ξ³ gene on late-onset Alzheimer's disease in the eastern Chinese Han population. | Geng S et al. | β | 2017 | β |
| Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population. | Wang S et al. | β | 2017 | β |
| Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer's Disease. | Wang ZX et al. | β | 2017 | β |
| Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components. | Raghavan N et al. | β | 2017 | β |
| Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study. | Bressler J et al. | β | 2017 | β |
| Genetic variation associated with the occurrence and progression of neurological disorders. | Little J et al. | β | 2017 | β |
| Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. | Deming Y et al. | β | 2017 | β |
| Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE Ξ΅4 variant. | Burggren AC et al. | β | 2017 | β |
| Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer's Disease. | Urfer-Buchwalder A et al. | β | 2017 | β |
| Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease. | de la Rubia OrtΓ JE et al. | β | 2017 | β |
| Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer's Disease Patients. Relevant Role of Neutrophils in Oxidative Stress. | Vida C et al. | β | 2017 | β |
| Inference of Causative Genes for Alzheimer's Disease Due to Dosage Imbalance. | Sekine M et al. | β | 2017 | β |
| Inhibition of Inflammation Mediated Through the Tumor Necrosis Factor Ξ± Biochemical Pathway Can Lead to Favorable Outcomes in Alzheimer Disease. | Shamim D et al. | β | 2017 | β |
| Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives. | Dong HK et al. | β | 2017 | β |
| Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process. | Su F et al. | β | 2017 | β |
| Interaction between PPAR Ξ³ and SORL1 gene with Late-Onset Alzheimer's disease in Chinese Han Population. | Zhang H et al. | β | 2017 | β |
| Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer's disease. | Kim D et al. | β | 2017 | β |
| Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study. | Andrews SJ et al. | β | 2017 | β |
| Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach. | Wang XF et al. | β | 2017 | β |
| Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer's disease. | Zakaria R et al. | β | 2017 | β |
| Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease. | Hayes JP et al. | β | 2017 | β |
| Multivariate association between single-nucleotide polymorphisms in Alzgene linkage regions and structural changes in the brain: discovery, refinement and validation. | Szefer E et al. | β | 2017 | β |
| Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array. | Barber IS et al. | β | 2017 | β |
| Outdoor Ambient Air Pollution and Neurodegenerative Diseases: the Neuroinflammation Hypothesis. | Jayaraj RL et al. | β | 2017 | β |
| PSEN1 gene polymorphisms in Caucasian Alzheimer's disease: A meta-analysis. | Ramakrishnan V et al. | β | 2017 | β |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. | Sims R et al. | β | 2017 | β |
| Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-Ι4 Homozygosity. | Louwersheimer E et al. | β | 2017 | β |
| Relationship of polymorphisms and haplotype in interleukin-16 and adiponectin gene with late-onset Alzheimer's disease risk. | Yin H et al. | β | 2017 | β |
| Relationships between cardiorespiratory fitness, hippocampal volume, and episodic memory in a population at risk for Alzheimer's disease. | Dougherty RJ et al. | β | 2017 | β |
| [Search for risk genes in Alzheimer's disease]. | Karaca I et al. | β | 2017 | β |
| Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis. | Roy J et al. | β | 2017 | β |
| SORL1 Is Associated with the Risk of Late-Onset Alzheimer's Disease: a Replication Study and Meta-Analyses. | Zhang CC et al. | β | 2017 | β |
| State of Play in Alzheimer's Disease Genetics. | Zhu JB et al. | β | 2017 | β |
| Subjective cognitive decline and Ξ²-amyloid burden predict cognitive change in healthy elderly. | Vogel JW et al. | β | 2017 | β |
| The effects of an extensive exercise programme on the progression of Mild Cognitive Impairment (MCI): study protocol for a randomised controlled trial. | Devenney KE et al. | β | 2017 | β |
| The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer's disease. | Rubin K et al. | β | 2017 | β |
| Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease. | Imm J et al. | β | 2017 | β |
| A Bacterial Component to Alzheimer's-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease. | Pretorius E et al. | β | 2016 | β |
| Advances in therapies and scope for personalized medicine in Alzheimer's disease. | Ravishankar HN et al. | β | 2016 | β |
| Aging Trajectories in Different Body Systems Share Common Environmental Etiology: The Healthy Aging Twin Study (HATS). | Moayyeri A et al. | β | 2016 | β |
| Altered memory-related functional connectivity of the anterior and posterior hippocampus in older adults at increased genetic risk for Alzheimer's disease. | Harrison TM et al. | β | 2016 | β |
| Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. | Pistollato F et al. | β | 2016 | β |
| Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks. | Castrillo JI et al. | β | 2016 | β |
| Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics. | Sala Frigerio C et al. | β | 2016 | β |
| Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment. | Louwersheimer E et al. | β | 2016 | β |
| A novel Alzheimer disease locus located near the gene encoding tau protein. | Jun G et al. | β | 2016 | β |
| An Overview of Genome-Wide Association Studies in Alzheimer's Disease. | Shen L et al. | β | 2016 | β |
| Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese. | Chang XL et al. | β | 2016 | β |
| Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer's Disease in Han Chinese. | Chi S et al. | β | 2016 | β |
| Associations between Sleep, Cortisol Regulation, and Diet: Possible Implications for the Risk of Alzheimer Disease. | Pistollato F et al. | β | 2016 | β |
| Association study of the PLXNA4 gene with the risk of Alzheimer's disease. | Wang H et al. | β | 2016 | β |
| Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration. | Wang HF et al. | β | 2016 | β |
| Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer's disease. | Umlauf E et al. | β | 2016 | β |
| Common and Rare Genetic Variants Associated With Alzheimer's Disease. | Marei HE et al. | β | 2016 | β |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society. | Winblad B et al. | β | 2016 | β |
| Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations. | Woodruff G et al. | β | 2016 | β |
| Defining the Genetic Architecture of Alzheimer's Disease: Where Next. | Sims R et al. | β | 2016 | β |
| Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. | Hohman TJ et al. | β | 2016 | β |
| Distributions of susceptibility loci to late onset Alzheimer's disease on human chromosomes. | Saadat M | β | 2016 | β |
| Education and Genetic Risk Modulate Hippocampal Structure in Alzheimer's Disease. | Baumgaertel J et al. | β | 2016 | β |
| Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. | Tan L et al. | β | 2016 | β |
| Evaluating the contribution of genetics and familial shared environment to common disease using the UK Biobank. | MuΓ±oz M et al. | β | 2016 | β |
| Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3. | Herold C et al. | β | 2016 | β |
| Family History of Alzheimer's Disease and Cortical Thickness in Patients With Dementia. | Ganske S et al. | β | 2016 | β |
| From Common to Rare Variants: The Genetic Component of Alzheimer Disease. | Nicolas G et al. | β | 2016 | β |
| Fus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory Impairments. | Coronas-Samano G et al. | β | 2016 | β |
| Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation. | Farnsworth B et al. | β | 2016 | β |
| Genes associated with Alzheimer's disease: an overview and current status. | Giri M et al. | β | 2016 | β |
| Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-Ξ²40 and Amyloid-Ξ²42 Peptides and ABCA7 Transcription in Cell Culture Models. | Bamji-Mirza M et al. | β | 2016 | β |
| Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond. | Cuyvers E et al. | β | 2016 | β |
| Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease. | Watson CT et al. | β | 2016 | β |
| Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. | Hohman TJ et al. | β | 2016 | β |
| Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders. | Wang C et al. | β | 2016 | β |
| Impact of PICALM and CLU on hippocampal degeneration. | Yang X et al. | β | 2016 | β |
| Impact of SORL1 genetic variations on MRI markers in non-demented elders. | Yin RH et al. | β | 2016 | β |
| Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain. | Smith AR et al. | β | 2016 | β |
| Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy. | Yang J et al. | β | 2016 | β |
| Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors. | Uchoa MF et al. | β | 2016 | β |
| Mathematical model on Alzheimer's disease. | Hao W et al. | β | 2016 | β |
| Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease. | Cadonic C et al. | β | 2016 | β |
| MEF2C rs190982 polymorphism with late-onset Alzheimer's disease in Han Chinese: A replication study and meta-analyses. | Tang SS et al. | β | 2016 | β |
| miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease. | Delay C et al. | β | 2016 | β |
| Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells. | Mungenast AE et al. | β | 2016 | β |
| Molecular genetics of early-onset Alzheimer's disease revisited. | Cacace R et al. | β | 2016 | β |
| Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease. | Dumanski JP et al. | β | 2016 | β |
| Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China. | Zhang W et al. | β | 2016 | β |
| New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics. | Lutz MW et al. | β | 2016 | β |
| Next Generation Sequencing in Alzheimer's Disease. | Bertram L | β | 2016 | β |
| Non-parametric Survival Analysis of EPG5 Gene with Age at Onset of Alzheimer's Disease. | Wang KS et al. | β | 2016 | β |
| Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. | Devassy JG et al. | β | 2016 | β |
| Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. | Jiang T et al. | β | 2016 | β |
| Polygenic risk of Alzheimer disease is associated with early- and late-life processes. | Mormino EC et al. | β | 2016 | β |
| Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer's Disease. | Jin SC et al. | β | 2016 | β |
| PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease. | Hampel H et al. | β | 2016 | β |
| Pro198Leu polymorphism affects the selenium status and GPx activity in response to Brazil nut intake. | Cardoso BR et al. | β | 2016 | β |
| RNA-Sequencing to Elucidate Early Patterns of Dysregulation Underlying the Onset of Alzheimer's Disease. | Chen BJ et al. | β | 2016 | β |
| Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease. | Kohli MA et al. | β | 2016 | β |
| SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan. | Chou CT et al. | β | 2016 | β |
| Systems Biology of Alzheimer's Disease. Preface. | Castrillo JI et al. | β | 2016 | β |
| TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits. | Wang H et al. | β | 2016 | β |
| The genetic landscape of Alzheimer disease: clinical implications and perspectives. | Van Cauwenberghe C et al. | β | 2016 | β |
| Toward precision medicine in neurological diseases. | Tan L et al. | β | 2016 | β |
| Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer's and Amyotrophic Lateral Sclerosis Brains. | Wang H et al. | β | 2016 | β |
| 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. | Weiner MW et al. | β | 2015 | β |
| A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans. | Martinez BA et al. | β | 2015 | β |
| Adjusting heterogeneous ascertainment bias for genetic association analysis with extended families. | Park S et al. | β | 2015 | β |
| A Human-Based Integrated Framework for Alzheimer's Disease Research. | Pistollato F et al. | β | 2015 | β |
| Alcohol-induced blackouts and maternal family history of problematic alcohol use. | Marino EN et al. | β | 2015 | β |
| Allobetulin derived seco-oleananedicarboxylates act as inhibitors of acetylcholinesterase. | Heller L et al. | β | 2015 | β |
| Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci. | Humphries C et al. | β | 2015 | β |
| Alzheimer's disease and the elderly in Israel: are we paying enough attention to the topic in the Arab population? | Werner P et al. | β | 2015 | β |
| Alzheimer's disease research in the context of the national plan to address Alzheimer's disease. | Snyder HM et al. | β | 2015 | β |
| A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. | Chen JA et al. | β | 2015 | β |
| Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. | Kumar NT et al. | β | 2015 | β |
| Apolipoprotein E Ξ΅-4 as a genetic determinant of Alzheimer's disease heterogeneity. | Kotze MJ et al. | β | 2015 | β |
| Association between polymorphisms in Interleukin-16 gene and risk of late-onset Alzheimer's disease. | Anvar NE et al. | β | 2015 | β |
| Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations. | Mao YF et al. | β | 2015 | β |
| Bridging Integrator 1 (BIN1) Genotype Effects on Working Memory, Hippocampal Volume, and Functional Connectivity in Young Healthy Individuals. | Zhang X et al. | β | 2015 | β |
| Can insulin signaling pathways be targeted to transport AΞ² out of the brain? | Vandal M et al. | β | 2015 | β |
| CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of Ξ²-secretase. | Singh AK et al. | β | 2015 | β |
| Chronic Noise Exposure Acts Cumulatively to Exacerbate Alzheimer's Disease-Like Amyloid-Ξ² Pathology and Neuroinflammation in the Rat Hippocampus. | Cui B et al. | β | 2015 | β |
| Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial. | Zhang Y et al. | β | 2015 | β |
| Co-morbid beta-amyloid toxicity and stroke produce impairments in an ambiguous context task in rats without any impairment in spatial working memory. | Keeley RJ et al. | β | 2015 | β |
| Convergent genetic and expression data implicate immunity in Alzheimer's disease. | International Genomics of Alzheimer's Disease Consortium (IGAP) | β | 2015 | β |
| Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. | Young JE et al. | β | 2015 | β |
| Examination of candidate exonic variants for association to Alzheimer disease in the Amish. | D'Aoust LN et al. | β | 2015 | β |
| Exome and whole genome sequencing in aging and longevity. | van den Akker EB et al. | β | 2015 | β |
| Gene interactions and structural brain change in early-onset Alzheimer's disease subjects using the pipeline environment. | Moon SW et al. | β | 2015 | β |
| Genetic determinants of disease progression in Alzheimer's disease. | Wang X et al. | β | 2015 | β |
| Genetic Determinants of Survival in Patientswith Alzheimerβs Disease. | Wang X et al. | β | 2015 | β |
| Genetic Risk Score Predicts Late-Life Cognitive Impairment. | Wollam ME et al. | β | 2015 | β |
| Genome-wide copy-number variation study of psychosis in Alzheimer's disease. | Zheng X et al. | β | 2015 | β |
| Geographical variation in dementia: examining the role of environmental factors in Sweden and Scotland. | Russ TC et al. | β | 2015 | β |
| Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease. | Yan J et al. | β | 2015 | β |
| HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study. | Leduc V et al. | β | 2015 | β |
| Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. | Hossini AM et al. | β | 2015 | β |
| Infection, systemic inflammation, and Alzheimer's disease. | Lim SL et al. | β | 2015 | β |
| Integration of 'omics' data in aging research: from biomarkers to systems biology. | Zierer J et al. | β | 2015 | β |
| Mechanisms of Long Non-coding RNAs in Mammalian Nervous System Development, Plasticity, Disease, and Evolution. | Briggs JA et al. | β | 2015 | β |
| MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data. | Satoh J et al. | β | 2015 | β |
| Molecular imaging in genetics. | Leite J et al. | β | 2015 | β |
| Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. | Bhat AH et al. | β | 2015 | β |
| Oxidized cholesterol as the driving force behind the development of Alzheimer's disease. | Gamba P et al. | β | 2015 | β |
| Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China. | Jiao B et al. | β | 2015 | β |
| Protective variant for hippocampal atrophy identified by whole exome sequencing. | Nho K et al. | β | 2015 | β |
| Structural Brain Changes in Early-Onset Alzheimer's Disease Subjects Using the LONI Pipeline Environment. | Moon SW et al. | β | 2015 | β |
| Structural Neuroimaging Genetics Interactions in Alzheimer's Disease. | Moon SW et al. | β | 2015 | β |
| Tau-mediated synaptic damage in Alzheimer's disease. | Jadhav S et al. | β | 2015 | β |
| The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans. | Kang JH et al. | β | 2015 | β |
| The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent. | Yates SC et al. | β | 2015 | β |
| The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options? | Grassmann F et al. | β | 2015 | β |
| The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-Ξ² Production in Alzheimer's Disease. | Zuo L et al. | β | 2015 | β |
| What Does Genetics Tell Us About Age-Related Macular Degeneration? | Grassmann F et al. | β | 2015 | β |
| ABCA7 gene and the risk of Alzheimer's disease in Han Chinese in Taiwan. | Liao YC et al. | β | 2014 | β |
| A gene-brain-cognition pathway for the effect of an AlzheimerΧ³s risk gene on working memory in young adults. | Stevens BW et al. | β | 2014 | β |
| Alzheimer's disease--a panorama glimpse. | Zhao LN et al. | β | 2014 | β |
| Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. | Proitsi P et al. | β | 2014 | β |
| ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease. | Medway CW et al. | β | 2014 | β |
| Apolipoprotein E in Alzheimer's disease: an update. | Yu JT et al. | β | 2014 | β |
| Clinical genetics of Alzheimer's disease. | Zou Z et al. | β | 2014 | β |
| Cognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view. | Walhovd KB et al. | β | 2014 | β |
| Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain. | Condliffe D et al. | β | 2014 | β |
| CSF in Alzheimer's disease. | Zetterberg H et al. | β | 2014 | β |
| Early identification and heritability of mild cognitive impairment. | Kremen WS et al. | β | 2014 | β |
| Early onset Alzheimer's disease and oxidative stress. | Meraz-RΓos MA et al. | β | 2014 | β |
| Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo. | Guerchet M et al. | β | 2014 | β |
| Epigenetic mechanisms in Alzheimer's disease. | Balazs R | β | 2014 | β |
| Evidence for modest familial co-aggregation between dementia and parkinsonism. | Feldman AL et al. | β | 2014 | β |
| Gene-based rare allele analysis identified a risk gene of Alzheimer's disease. | Kim JH et al. | β | 2014 | β |
| Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes. | Gharesouran J et al. | β | 2014 | β |
| Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. | Ringman JM et al. | β | 2014 | β |
| Genetic loci associated with Alzheimer's disease. | Reitz C | β | 2014 | β |
| Genetics of PICALM expression and Alzheimer's disease. | Parikh I et al. | β | 2014 | β |
| Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals. | Tan MS et al. | β | 2014 | β |
| Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. | Escott-Price V et al. | β | 2014 | β |
| Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease. | Talwar P et al. | β | 2014 | β |
| Genomics in neurological disorders. | Han G et al. | β | 2014 | β |
| Genomics of ageing in twins. | Mangino M | β | 2014 | β |
| Identification of rare variants in Alzheimer's disease. | Lord J et al. | β | 2014 | β |
| Interleukin-23 receptor polymorphisms are associated with Alzheimer's disease in Han Chinese. | Liu Y et al. | β | 2014 | β |
| Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease. | Sassi C et al. | β | 2014 | β |
| Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways. | Rosenthal SL et al. | β | 2014 | β |
| Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice. | Wang P et al. | β | 2014 | β |
| NRG3 gene is associated with the risk and age at onset of Alzheimer disease. | Wang KS et al. | β | 2014 | β |
| Psychiatrists' views of the genetic bases of mental disorders and behavioral traits and their use of genetic tests. | Klitzman R et al. | β | 2014 | β |
| Rare Variants and Transcriptomics in Alzheimer disease. | Humphries C et al. | β | 2014 | β |
| RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains. | Satoh J et al. | β | 2014 | β |
| Single nucleotide polymorphism rs7294919 on chromosome 12q24.22 is associated with late-onset Alzheimer's disease in Han Chinese. | Ma LL et al. | β | 2014 | β |
| The mitochondrial epigenome: a role in Alzheimer's disease? | Devall M et al. | β | 2014 | β |
| There are no differences in IL-6, CRP and homocystein concentrations between women whose mothers had AD and women whose mothers did not have AD. | DevΔiΔ S et al. | β | 2014 | β |
| The TRiC/CCT chaperone is implicated in Alzheimer's disease based on patient GWAS and an RNAi screen in AΞ²-expressing Caenorhabditis elegans. | Khabirova E et al. | β | 2014 | β |
| Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-Ξ² accumulation modifier. | Morihara T et al. | β | 2014 | β |
| A common copy number variation (CNV) polymorphism in the CNTNAP4 gene: association with aging in females. | Iakoubov L et al. | β | 2013 | β |
| ADAM10 missense mutations potentiate Ξ²-amyloid accumulation by impairing prodomain chaperone function. | Suh J et al. | β | 2013 | β |
| Age-dependent effect of Alzheimer's risk variant of CLU on EEG alpha rhythm in non-demented adults. | Ponomareva N et al. | β | 2013 | β |
| APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease. | Donix M et al. | β | 2013 | β |
| Ashwagandha (Withania somnifera) reverses Ξ²-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). | Kurapati KR et al. | β | 2013 | β |
| Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration. | Honea RA et al. | β | 2013 | β |
| CLU genetic variants and cognitive decline among elderly and oldest old. | Mengel-From J et al. | β | 2013 | β |
| Genetic testing and Alzheimer's disease: implications for psychiatric-mental health nursing. | Schutte DL | β | 2013 | β |
| Genome-wide association studies in Alzheimer's disease: a review. | Tosto G et al. | β | 2013 | β |